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ABSTRACT 
 
Characterization of the Drosophila Scaffold Attachment Factor B (SAFB). 
(August 2010) 
Catalina Alfonso Parra, B.S., Universidad de Los Andes 
Co-Chairs of Advisory Committee: Dr. Keith Maggert  
         Dr. Sumana Datta 
   
 Gene expression is a process that involves changes in chromatin 
organization and structure. Chromatin is thought to be organized in a structure 
consisting of looped domains, which are fixed at their bases to the nuclear 
matrix or scaffold. SAFB has been identified as a nuclear matrix binding protein 
in humans. Human SAFBs contain an N-terminal DNA-binding SAP-Box, and an 
RNA recognition motif (RRM). However it is unknown how the features of SAFB 
are linked to gene expression and chromatin organization. I have identified a 
single homologue of SAFB in Drosophila. To understand the role of SAFB in 
gene expression and nuclear structure, I have begun to characterize Drosophila 
SAFB. I found two SAFB splice forms, a full length SAFB containing DNA and 
RNA binding domains, and a smaller splice form lacking the RNA binding 
domain. I have showed that SAFB is expressed throughout embryogenesis, in 
adult testis and ovaries, and larval and adult brains. In addition, I made SAFB-
GFP constructs to characterize the cellular localization of SAFB. In S2 cells, 
embryos and neuroblasts, GFP-SAFB was found throughout the nucleus and in 
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nuclear speckles and is retained in the matrix after soluble proteins and DNA are 
removed. Using larval polytene chromosomes, I show that GFP-SAFB binds to 
specific DNA bands, some of them overlapping with RNA Polymerase II. After 
heat shock, GFP-SAFB is recruited to the highly expressed heat shock genes. 
Treatment of polytene chromosomes with RNAse caused the majority of bands 
to disappear, meaning that the binding of most of SAFB to chromosomes was 
mostly through RNA. To distinguish binding of SAFB to DNA from protein-protein 
interaction, I constructed a GFP-tagged version of SAFB lacking the SAP 
domain, which binds to fewer sites in the genome. RNAse treatment abolished 
nearly all binding. Together, my data show that Drosophila SAF-B is a 
component of the nuclear matrix, that localized to specific loci in the 
chromosomes, and is recruited to actively-transcribed genes.  
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CHAPTER I 
INTRODUCTION 
 
 
 Since its discovery in the early 1800s, it has been clear that the 
eukaryotic nucleus is highly organized. However, the fundamental question of 
how chromatin is arranged within the nucleus, and its role in DNA replication 
and in transcription is still unclear. Its been long known that a diploid eukaryotic 
nucleus contains about 2 meters of DNA, which needs to be packed into a 
nucleus that is ~10um in diameter. To do so, cells organize their genetic 
information into a complex containing DNA and structural and regulatory 
proteins, although many aspects of this compaction are not known. In the end, 
this arrangement organizes the nucleus into specialized domains based on 
function, such as transcription and RNA factories, and chromatin structure—
such as association of heterochromatin with the nucleus periphery. Therefore, 
chromatin organization plays an important role in numerous cellular functions, 
allowing gene transcription, DNA replication and other processes to occur in an 
efficient and ordered way. Understanding whether nuclear architecture is a 
cause or a consequence of these cellular functions - and how they are related - 
is crucial for understanding phenotypic-specific gene expression, differential 
____________ 
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Sciences (PNAS). 
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expression in specific cell-types and during embryogenesis and alterations in 
malignancy (such as cancer). To understand the characteristics and functions 
of nuclear matrix, it is imperative that we first understand its main components.    
 
CHROMATIN ORGANIZATION  
 
Chromatin compaction 
 
 Eukaryotic genomic DNA is packed into a nucleoprotein complex known 
as chromatin. This chromatin complex is sufficiently compacted not only for the 
entirety of the DNA to fit within the nucleus, but also to allow cellular functions 
to proceed normally. The compaction of the DNA into the nucleus has many 
levels of organization (Fig. 1). In the first level, DNA is compacted 5-10 fold, 
forming a 10-nm fiber. This basic level is the nucleosome, where 146-165 base 
pairs of double-stranded DNA are wrapped around an octamer of histone 
proteins, known as the nucleosome core particle. The histone octamer is 
formed by two each of four core histones: H2A, H2B, H3 and H4. Histones can 
affect chromatin organization by being chemically modified, or by being 
replaced by other histone variants. Furthermore, histone modifications play 
important roles in gene expression, replication and repair by limiting the 
availability of DNA sequences to be bound by specific proteins or by making a 
specific “code” that can be recognized by other proteins, creating or inhibiting 
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particular complex formation (Fig. 2) (1). 
 
 
 
 
Fig. 1. Hierarchical levels of DNA organization in the eukaryotic nucleus. 
Adapted from (2). 
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Fig. 2. Primary level of chromatin compaction. Nucleosomes are the basic 
structure unit in eukaryotic chromatin, where DNA wraps around a histone 
octamer. Post-translational modifications of the histone core affect DNA 
compaction and act as signaling components for various proteins. 
 
 
 
The second level of compaction, the 30-nm fiber, is the result of an 
organized 10-nm fiber stabilized with the help of histone H1, which fixes the 
angle with which linker DNA enters and exits the nucleosome. However, the 
arrangement of the fiber is so compact that the exact structure has remained 
unsolved despite significant efforts.  
Different models have been proposed to describe the native fiber 
structure. The solenoid model proposes that about six to eight nucleosomes 
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per turn are folded into a helical array, with the linker histone H1 on the inside 
of the filament (Fig. 3A). A variant of this model proposes that two rows of 
nucleosomes form, in which the linker DNA is parallel to the fiber axis, forming 
a zigzag (Fig. 3B). In another study, Bednar et al. (3) suggested that there is a 
“stem” conformation of the linker DNA segment that is histone dependent. This 
stem conformation is generated by the entry and exit of the linker DNA into the 
nucleosome (4, 5).  
 
 
 
                              
Fig. 3. Two proposed models of the 30 nm Chromatin Fiber. A. In the solenoid 
model the fiber is a one-start helix .B. In the zigzag model the fiber is a two-
start helix. Adapted from (4). 
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Much less is known about the next level of compaction, in which the 
chromatin fiber is organized into loop domains. The 30-nm fiber is bound by 
periodic and specific attachments to a matrix of proteins to form independent 
loops. The loop domains are very important as they represent structural units 
of chromatin associated with DNA replication, gene expression and higher 
order packaging. However, molecular-cytological information defining the loop 
domain and its role in cellular functions is lacking (6). 
 
Chromatin loop  
 
 It is hypothesized that loop domains are necessary for chromatin 
packaging within the nucleus while providing the flexibility to complete different 
nuclear processes. To organize the fiber into loops, non-histone scaffold 
proteins bind to specific DNA regions called scaffold attachment regions 
(SARs). In 1975, Cook et al. (3) first proposed that loop structures are involved 
in a higher level of chromosome organization. Later, Laemmli et al. (7) 
furthered the understanding of scaffold structure by developing an extraction 
procedure that preferentially removed histones and other soluble proteins from 
chromosomes without altering the higher order of chromatin organization. The 
result was histone-depleted chromatin that maintained a loose chromosome-
shaped structure called the scaffold, surrounded by a large halo of 50 to 100 kb 
DNA loops (Fig. 4). It is now accepted that the DNA loops observed are the 
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structural and functional unit of chromatin, responsible for gene expression and 
DNA replication (8, 9). 
 
 
 
                          
Fig. 4. Chromosomal scaffold as seen by electron microscopy. Extraction of 
the histones and other non-histone proteins results in unfolded chromosomes, 
consisting of a scaffold that retains the characteristic mitotic chromosome 
shape and is surrounded by a halo of DNA. The insert shows a scaled mitotic 
chromosome (8). 
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SARs: Scaffold Attachment Regions   
  
 Mammalian Scaffold Attachment Regions, SARs, are about 1 kb in length, 
have more than 70% AT content, and are considered the basis of DNA loops 
(Fig. 5). To characterize SARs, Laemmli et al. (10) stained metaphase 
chromosomes with the AT-specific dye daunomycin, showing that AT 
sequences line up along the chromosome axis. Specific interactions between 
SARs and scaffold proteins are not due to a particular base sequence, but 
rather are determined by the structural characteristics of the A rich sequences 
(A-tracks), such as a narrower minor groove and other particular DNA bends. 
These structural-base interactions have been demonstrated by using the 
peptide antibiotic distamycin, which binds to the narrow minor groove of A-
tracts and inhibits biochemical interactions of some scaffold proteins with SARs 
(11).   
In addition to their role in chromosome compaction, SARs have been 
shown to be required for high expression of certain genes, either by 
association with enhancer elements, increasing transcription initiation rates, or 
insulating particular sequences - giving physical separation to different 
transcription units. In adittion, SARs are also associated with chromosomal 
replication and recombination events (12). Although some reports suggest that 
loops are randomly organized, others have demonstrated an enrichment of 
repeated DNA sequences or single-copy genes (13). Regardless, the reason 
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why chromatin is organized into loops is still unclear. 
 
 
 
Fig. 5. The mitotic chromosome scaffold. A high level of DNA compaction is 
achieved by the formation of loops, attached at their bases to a network of non-
histone proteins that comprise the chromosomal scaffold. The entire nature of 
loop formation is unknown.  
 
 
 
Scaffold proteins  
 
In higher eukaryotes, a number of proteins that bind SARs in vitro have 
been identified. SAR-scaffold protein interactions depend mostly on recognition 
of structural features and result from the binding of several SAR sequences 
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that cooperate to achieve high specificity (Fig. 5). Since the structural packing 
is dynamic during the cell cycle, going from interphase chromatin arrangement 
to a compact metaphase chromosome, these proteins can be divided 
depending on whether they are extracted from the metaphase or interphase 
scaffold. The metaphase-specific proteins include the condensin complex and 
topoisomerase II (Topo II), which are essential for mitotic chromosome 
condensation. Interphase scaffold preparations have been shown to contain 
RNA and ribonucleoprotein as major components. A subset of SAR binding 
proteins have been found in both preparations, including actin, DNA and RNA 
polymerases, Scaffold Attachment Factors A and B, and Attachment Region 
Binding Protein ARBP (14). 
 
 NUCLEAR MATRIX 
 
 While it is still unclear how chromatin is organized within the nucleus, it is 
known that its components and processes are not random. For instance, 
replication factories and transcribed genes are found in discrete foci, and 
during interphase each chromosome is located in a specific territory. How does 
the nucleus maintain its internal organization? It is believed that the nuclear 
matrix is the network that provides a framework for nuclear processes to occur. 
However the significance of the nuclear matrix is not clear and in some cases 
its very existence, still in question (15). 
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The term nuclear matrix was originally used by Berezney and Coffey, 
following on previous studies, to describe a residual structure following nuclear 
isolation from rat tissue (16). The structure of the nuclear matrix was revealed 
when nuclei were treated with high salt (to extract the soluble proteins present) 
and DNAse I (to remove the DNA that is not bound to insoluble proteins). 
Electron microscopy showed that the matrix that remained preserved the 
overall nuclear form and size.  
The nuclear matrix is a proteinaceous, RNA-rich network that consists of 
residual nucleoli, internal matrix, lamina complex, and surrounding nuclear 
pores (17). DNA sequences, splicing intermediates, splicing cofactor proteins, 
and pre-mRNA are also present in nuclear matrix preparations (18). This 
dynamic structure is present in interphase and metaphase chromosomes, with 
the latter lacking a nuclear envelope and lamina. It is not known if the nuclear 
matrix rearranges or is degraded and reformed depending on the cell cycle 
phase.  
 
DNA - Nuclear matrix association 
 
 When interphase nuclei are depleted of histones and soluble proteins 
using high-strength ionic buffers - like histone-depleted chromosomes - an 
insoluble protein matrix surrounded by a halo of 30-100 kb DNA loops remains 
(19). This result supports the idea that DNA is anchored to a structure, the 
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nuclear matrix. The DNA sequences associated with the nuclear matrix have 
been called Matrix Attachment Regions or MARs. Moreover, since it has been 
shown that the Scaffold Attachment Region and Matrix Attachment Region 
have similar characteristics, they are also called S/MARs. 
S/MARs were originally identified as DNA elements with a high affinity 
for the nuclear matrix. Characterization of these DNA sequences, were done 
biochemically using isolated nuclear matrices or histone-depleted nuclei. 
S/MARs were first defined operationally by their ability to bind isolated nuclear 
matrix proteins, or by characterizing the sequences that remain attached to the 
nuclear matrix in histone-depleted nuclei (13). Since then, more work has been 
done trying to identify S/MARs sequences. For instance, SAR sequences have 
been mapped along large, continuous regions of the Drosophila genome and 
were found at intervals that varied roughly between 10 kb and 100 Kb (20). 
S/MARS are 200-1000 bp of AT-rich stretches with a few conserved 
motifs, but in general there is not a sequence associated with them. 
Furthermore, S/MARs are sequences with altered topology creating a non B-
form DNA. Specific point mutations that cause structural changes of artificial 
SARs were found to inhibit their interaction with the nuclear matrix (21, 22). 
It is believed that S/MARs are bound to the nuclear matrix either 
constitutively or transiently. In the former case, S/MARs are likely to be 
preserving the chromatin structure of interphase and metaphase 
chromosomes, possibly demarcating permanent loop boundaries in all cell 
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types. In the latter case, facultative or transient S/MARs have a more dynamic 
association and are related to a specific cell type or specific activity, such as 
gene expression or DNA replication (12).  
Some proteins of the nuclear matrix have been described as proteins 
that bind S/MARs. They can be divided into those that bind specifically to 
S/MARs, such as SATB1 and some hnRNP proteins, or those that bind 
preferentially, but not exclusively, to S/MARs, such as topoisomerase II (17). 
Additionally, proteins that bind to S/MARs can also be divided depending on 
whether they bind to constitutive or facultative S/MARs. 
 
Nuclear matrix proteins 
 
 Nuclear matrix proteins are the non-histone proteins that remain in the 
nuclear matrix after nuclease and high salt extraction of isolated cell nuclei. 
They associate tightly with S/MARs to form the chromatin loops. In addition, 
these interactions must be preserved throughout mitosis. The nuclear matrix 
has never been observed in intact living cells, so it is unknown which proteins 
form its structure. However, several nuclear proteins have been identified 
biochemically. A recent study suggests that over 400 nuclear matrix proteins 
exist, of which 50% are constitutive components of the nuclear matrix (23, 24). 
There are also nearly 130 other proteins whose binding is cell cycle regulated 
or cell type dependent (23, 24). It is still not clear how proteins are incorporated 
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to the nuclear matrix, but one possible explanation is provided by the post-
translational state of the proteins, based on studies done first by Allen et al. 
(25) and continued by Henry and Hodge (26), showing differences in 
phosphorylation of nuclear matrix proteins at various times during the cell 
cycle. More evidence came from a study done by Mittnacht et al. (27), where it 
was shown that the phosphorylated tumor suppressor Rb protein associates 
with the nuclear matrix predominantly during G1, but as cells progress through 
G1, the degree of phosphorylation increases, while the association with the 
nuclear matrix decreases.  
Additional studies have associated phosphorylated proteins and kinases 
with the nuclear matrix (28, 29). Some of these proteins, such as matrins, 
lamins, Nuclear Mitotic Apparatus Protein (NuMA), Attachment Region Binding 
Protein (ARBP) and scaffold proteins, are candidates for structural components 
of the nuclear matrix. Another group of proteins may play a regulatory role in 
the matrix functions, such as High-Mobility Group proteins 1 and 2, 
Topoisomerase II, and a variety of kinases (30). Some other transitory proteins 
have been found in nuclear matrix preparations, such as PARP, p53, CTCF, 
that function in various pathways in the cells, from epigenetic regulation to 
apoptosis and DNA repair (31, 32).  
As a result of the great mixture of proteins associated with the nuclear 
matrix, a variety of functions have been given to this structure, from chromatin 
assembly, DNA replication, and transcriptional association, but the exact 
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significance of the association of those proteins to the nuclear matrix has yet to 
be determined.  
 
NUCLEAR MATRIX FUNCTIONS 
  
Nuclear matrix and DNA replication 
 
 Perhaps one of the most complex functions of the cell is DNA replication, 
where once per cell cycle the genome is copied accurately in an organized 
manner. Replication of eukaryotic chromosomes occurs in about 50,000 
independent loci known as replicons. Up to 100 or more replicons are clustered 
into foci, which fire simultaneously in S phase. After replication of the 
respective replicons is complete, foci fade and disappear while new foci appear 
at the next site of replication (Fig. 6) (33).  
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Fig. 6. DNA replication factories. MRC5 cells pulse-labeled with EdU, labelling 
newly synthesized DNA. Cells were also labeled for PCNA, which acts as a 
processivity factor for DNA polymerase in eukaryotic cells. Adapted from (34). 
 
 
 
Initially, it was proposed that DNA polymerases were found all over the 
nucleus, but their punctuate appearance suggests that polymerases come 
together into foci at the time of DNA replication. The organization of the foci 
raises the question: what controls the spatial and temporal patterns of 
replication during the entire cell cycle? Recent findings point to the nuclear 
matrix as the foundation in which replication occurs. First, it is documented that 
S/MAR sequences are present in the vicinity of the origins of replication, and 
some of the most completely characterized origins of replication, mainly in 
yeast, have been mapped to AT-rich genomic regions (35). In fact, it has been 
shown that a minimal SARs, a tetramer of 155bp, linked to an upstream 
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transcription unit is sufficient for the replication and mitotic stability of a 
mammalian episome (36). Secondly, DNA synthesis occurs at replication sites 
of nuclear matrix structures that are indistinguishable from those found in intact 
cells (37). Further support comes from a study showing that components from 
replication machinery, such as DNA polymerase α, primase, and other 
replication components are associated with the isolated nuclear matrix (15). 
Consistent with this, it is predicted that replicating loops corresponding to 
individual replicon subunits are bound to the nuclear matrix, and bidirectional 
replication then occurs by the reeling of DNA through replication “factories” 
(35).  
There is clear evidence that the nuclear matrix is involved in at least two 
of the three stages of DNA replication: Initiation and Elongation. Initiation 
begins at the origins of replication, and comprises all the events preceding the 
beginning of DNA synthesis. There is evidence that the nuclear matrix is 
necessary for initiation. First, Origins of Replication are found attached to the 
nuclear matrix in late G1 phase prior to firing and dissociated after the initiation 
of DNA replication has been completed in S phase (Fig. 7). Additionally it is 
possible to initiate replication in isolated matrix preparations (38, 39). Second, 
crucial initiation factors are attached to the nuclear matrix, for instance ORC 2-
5 are temporally recruited and tethered to the nuclear matrix (40).  
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 During elongation, DNA is replicated bi-directionally away from the origin 
of replication. Replication forks remain stationary during the process, while the 
replicating DNA is reeled through and the replicated DNA moves away (41). 
Even though the specific details are not fully understood, models have been 
proposed based on the available evidence. For instance, there is data showing 
that origins are permanently attached to the nuclear matrix (42). Also, it is 
known that DNA is replicated at the bases of the loops by DNA polymerase 
complexes attached to the nuclear matrix while newly synthesized DNA moves 
to the periphery of the loops (Fig. 7) (19, 43). 
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Fig. 7. A model of DNA replication at the nuclear matrix. In early G1, SMARs 
bind to the nuclear matrix at regions defining the replicons. In late G1, origin of 
replication (ORIs) and associated replication factors are recruited to the 
nuclear matrix. When the cell enters the S phase, newly replicated ORIs and 
DNA dissociate from the nuclear matrix (shown in blue) while the rest of DNA 
in the replicons moves through the replication factory. At the end of S-phase, 
the replication machinery and replicated DNA is dissociated from the nuclear 
matrix. Adapted from (35). 
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Taken together, these results show that the nuclear matrix plays a role 
in DNA replication by providing structural support. Nevertheless, there are still 
studies that question the models based mainly on our lack of evidence of the 
nuclear matrix in vivo.    
 
 Nuclear matrix and transcription  
 
 During the past decade, numerous studies have tried to link gene 
expression to nuclear localization. Heterochromatin and gene-poor 
chromosomes have been linked to the nuclear periphery, while gene-rich 
chromosomes and euchromatin have been associated with an internal location. 
Unfortunately, some studies suggest a more complex situation, based on 
active transcription in the nuclei periphery detecting by nascent RNA (44). In 
addition, it has been shown that Nuclear Pore Complexes (NPCs) are areas of 
high transcriptional activity (45). But is there a real link between nuclear 
localization and gene expression? 
In eukaryotic cells, transcription requires organized regulation of the 
proteins and complexes necessary for mRNA synthesis within the nucleus. 
Over a long period of time, and based on experiments done by Miller in 1972, it 
has been proposed that RNA Polymerase II tracks along the DNA, synthesizing 
mRNA and trailing such transcripts behind them (Fig. 8). 
 21 
                       
 
Fig. 8. Transcription from tandemly arranged rRNA genes. Transcription of 
rRNA genes visualized by electron microscopy as seen in Miller spreads of 
nucleoli from salamander oocytes. It is believe that nascent RNA is attached to 
the tracking RNA polymerase, giving a christmas tree-like morphology. 
Adapted from (46).  
 
 
 
 Later, in 1987 Avri Ben-Ze’ev proposed a model in which transcription 
complexes were stationary while the DNA passes through as it is being 
transcribed. It is now known that transcription does not happen in a diffuse 
manner, instead occurring in hundreds of thousands of discrete foci. A dynamic 
process that reflects the cell cycle stage and overall transcriptional activity of 
the cell (Fig. 9a) (15). These foci contain transcription factors, phosphorylated 
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polymerase II and pre-mRNA processing factors. These factors may be in a 
foundation provided by the nuclear matrix, since all are retained in the nucleus 
following the removal of histones and DNA (Fig. 9b) (47-49).  
 
 
 
        
Fig. 9. Transcription foci in vitro. A. Run-on transcription was carried out in 
human bladder carcinoma cells to show transcription foci. As a control, α-
Amanitin was included during run-on to inhibit RNA polymerase II transcription. 
B. Run on transcription was performed using extracted nuclear matrix of 
human skin fibroblasts in the presence of BrUTP. As a control for the nuclear 
matrix extraction, Hoechst was used to stained remain DNA. Adapted from 
(44). 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The molecular mechanism of the nuclear matrix in transcription requires 
further study, but several models have been proposed that may help to direct 
such studies. A number of studies in gene expression have demonstrated that 
for at least some genes, S/MARs are enriched near or within enhancers or 
promoters (Fig.10). For example, studies of three developmentally regulated 
genes in Drosophila—Sgs-4, fushi tarazu and Adh— show that they all contain 
SAR regions within upstream regulatory elements, required to enhance their 
expression (50). Also, using HeLa S3 cells, Linneman and colleagues (51) 
showed that 5’ S/MARs are associated with actively transcribed genes of 
chromosomes 14-18.  
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Fig. 10. Enrichment of S/MAR sequences within or near promoters increases 
expression of the corresponding gene. 
 
 
 
 A DNA looping model has been proposed to explain different 
transcriptional levels of certain genes caused by nuclear matrix. In this model, 
loops bring distal elements, such as enhancers, into close proximity with 
promoters, with direct consequences on gene expression (Fig.11). One of the 
most studied nuclear matrix proteins, SATB1, has been shown to be required 
for the formation of transcriptionally active loops of the cytokine locus of T-
helper cells in the thymus, involved in the chromatin organization of the MHC-1 
locus (52). 
 25 
                  
Fig. 11. Formation of loops causes alteration in gene expression by bringing 
together regulatory sequences. 
 
 
 
 It is known that S/MARs act as boundary for the separation of 
euchromatin (or active chromatin) and heterochromatin (silent chromatin). It is 
believed that domains flanked by SARs may define independent units, possibly 
loops, that are unaffected by their sites of integration into the genome (Fig. 12). 
Flies that are transformed with a fushi tarazu sequence containing 5’ but not 3’ 
S/MARs, show position effect, but none of the transformants that received the 
entire locus with both SARs showed position effect (53). In Drosophila, the 5’ 
untranslated region of the gypsy retrotransposon contains an insulator, which 
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behaves as a S/MAR, disrupting the interaction between enhancer and 
promoter elements (54). Another set of experiments that show evidence of the 
importance of the nuclear matrix in boundary elements were done with 
BEAF32B. This protein, which is present in the nuclear matrix, binds to an 
insulator region next to the heat shock locus and inhibits the expansion of the 
puffs when the Heat Shock genes are actively transcribed (55). 
 
 
 
               
Fig. 12. Upstream and downstream S/MAR sequences act as boundary 
elements, defining independent transcription units. 
 
 
In addition, proteins from the nuclear matrix are able to form complexes 
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with proteins important in the regulation of gene expression. For instance, 
SATB1 acts as a docking site for many chromatin modifiers including ISWI and 
HDAC1, which suppresses expression near SATB1 bound S/MARs (56). 
Scaffold Attachment Factor A (SAF-A) binds to the transcriptional co-activator 
p300, which acetylates histones and other proteins mainly at promoter and 
enhancer elements (57). Similarly, SAF-A forms a complex with actin and 
Polymerase II, important for proper elongation of RNA transcripts (58). 
 Chromatin loops or specific nuclear matrix protein-S/MAR complexes 
confer special arrangements to the nucleus, a situation that might reflect 
specific location associated with gene transcription and silencing. It is known 
that some dynamically regulated genes are recruited to the nuclear periphery 
when activated (59). Also, artificial tethering of genes to the nuclear envelope 
in yeast enhances transcription (60). More recently, it was shown that at 
activation, the B-globin locus is localized to the nuclear periphery and only 
moves into the nuclear interior at a later time (1).   
 Further studies are necessary to understand the exact role of the nuclear 
matrix in the regulation of gene expression. This regulation may be explained 
by a combination of DNA looping, insulator activity, protein complex formation 
and nuclear localization—all of which can be dependent on the genes, cell type 
or cell cycle stage. The link between nuclear architecture and gene expression 
may be an important clue for understanding specific gene expression and the 
alteration of phenotypes in tumor malignancy (61). 
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Nuclear matrix and RNA splicing  
 
 Studies have provided evidence that the nuclear matrix is the structure on 
which some steps in RNA processing take place. A small amount of nuclear 
RNA is soluble, with over 95% of newly synthesized hnRNA remaining after 
nuclear matrix isolation procedures. Additionally, precursors of mRNAs and 
small RNA (snRNA) species are recovered along with the nuclear matrix (62). 
The high levels of RNA retention suggest that the nuclear matrix may play an 
important role in mRNA synthesis, processing and export.   
 During pre-mRNA splicing, non-coding sequences (introns) are removed 
from primary transcripts. Splicing reactions take place in large RNA-protein 
nuclear complexes called splicesomes. Indirect immunofluorescence labeling 
studies show that the nucleus contains between 20 and 50 domains containing 
high concentration of all the components of the splicing machinery, known as 
speckles or SFCs (splicing factor compartments). Some observations suggest 
that splicing takes place in the SFC, since polyA-RNA and several nascent 
transcripts are present in the speckles (63). However, other studies support the 
view that SFCs are not primary sites of pre-mRNA splicing, but instead appear 
to be storage/assembly areas for spliceosomal components (64). In addition to 
RNA, some components of the splicing machinery such as snRNPS (small 
nuclear ribonucleoprotein)(65), and non-snRNP such as PSF (66), SAF-A and 
SR (serine/arginine) proteins, are also associated with the nuclear matrix (67-
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69). In fact, nuclear matrices contain preassembled ribonucleoprotein 
complexes, which splice pre-mRNA efficiently when supplemented with soluble 
factors (70). After its synthesis, pre-mRNA as well as mature RNA molecules 
remain associated with the nuclear matrix (71, 72). Recent evidence indicates 
that RNA and ribonucleoprotein particles may themselves have a role in the 
nuclear matrix structure (73). 
  Further studies are needed to clarify how RNA splicing works as well as 
to understand the significance of targeting splicesosome proteins and RNA 
molecules to the nuclear matrix. 
 
Nuclear matrix and hormones  
 
 It is important to understand the molecular mechanism of specific 
responses from individual cells to a single type of hormonal signal. Initially, it 
was thought that when a particular hormone binds to a receptor, the receptor 
undergoes a conformational change that results in its binding to DNA elements 
ultimately altering gene transcription. Now, a more extensive understanding 
has revealed that hormone responses are extremely complex and regulated by 
a diverse set of cofactors and other nuclear signals. However, it is not well 
known how the hormone receptor can elicit responses from some tissue cells 
but not others in the same organism. A modulator of hormone action and a 
plausible explanation for its specificity is the nuclear matrix.  
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 The association of steroid receptors with the nuclear matrix has been 
studied for over 30 years, since it was observed that some steroid hormone 
receptors are resistant to solubilization with salt, similar to nuclear matrix 
proteins. The importance of the association between the nuclear matrix and 
nuclear receptors has been described in many steroid receptors, such as 
glucocorticoid receptor (GR), androgen receptor (AR), progesterone receptor 
(PR) and estrogen receptor (ER) (74-76). The binding of steroid receptors to 
the nuclear matrix appears to be hormone-dependent and involves high-affinity 
interactions (77). Binding of androgen receptor, glucocorticoid receptor and 
progesterone receptor to the nuclear matrix requires a DNA binding domain 
(DBD) and a carboxy-terminal ligand binding domain (LBD) (78). Mutation of 
any of those domains causes redistribution of the receptors to the cytoplasm 
and nucleus locations (79). 
 The levels of steroid receptors found to associated with the nuclear 
matrix vary among different target tissues and change in response to the 
hormonal status of the organism (77). After exposure to a ligand, a nuclear 
receptor commonly moves into foci within the nucleus—associated with 
transcriptional activity. Transfection of tagged receptors show that foci 
formation occurs in progesterone receptor (PR), estrogen receptor alpha (ERa) 
androgen receptor (AR), glucocorticoid receptor (GR), and mineralocorticoid 
receptor (MR). Studies done with PR show that binding to the nuclear matrix is 
essential for foci formation (79). In steroid receptors whose interaction with the 
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nuclear matrix depends on hormone signaling, the efficiency of their binding to, 
and the release from the nuclear matrix is very important for their ability to scan 
the genome, locate its target gene, and initiate its transcriptional activity (74). 
 In addition to the experiments showing the presence of steroid receptors 
in the nuclear matrix after extraction of soluble proteins and DNA, there are 
studies showing specific nuclear matrix proteins directly binding to hormone 
receptors and modulating their activity. This is the case in ER binding to 
Scaffold Attachment Factor B and GR interacting with Scaffold Attachment 
Factor A (80). Further studies show S/MARS sequences associated with 
promoters of target genes of steroid receptors (61). 
 
NUCLEAR MATRIX AND PATHOLOGY 
 
 Since nuclear matrix structure and functions have been intensively 
examined, determination of its role in various pathologies is being sought. A 
comparison between nuclear structure in normal vs. pathological cells implies 
that genome organization is perturbed in some disease. This implies that 
changes in chromatin architecture may be dependent on impairment of the 
nuclear matrix regulatory functions. The involvement of nuclear matrix in 
disease can be classified as to whether the pathogenesis is associated with (a) 
defects in the nuclear matrix proteins (normally hereditary diseases), (b) 
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changes in the localization of nuclear protein normally present in the nuclear 
matrix or (c) with S/MARs (81).  
 The first group involves laminopathies, hereditary diseases associated 
to structural defects of the lamina, a nuclear matrix. Some neuromuscular 
diseases, skeletal dysplasias and metabolic hereditary diseases are also the 
result of mutations in different nuclear matrix proteins (81). It is possible that 
chromatin changes are related to alteration of a proteins association with the 
nuclear matrix. Studies have shown that specific changes in nuclear matrix 
proteins are observed during tumor progression. Many cancer phenotypes, 
such as prostate carcinoma, colon cancer, cervical carcinoma and breast 
cancer, have been associated with presence or absence of certain nuclear 
matrix proteins (82). Some of these tumor–associated proteins are employed in 
clinical diagnosis. For example, NMP22 protein has been used for monitoring 
the recurrence of carcinoma of the urinary tract, and BLCA-4 is specific marker 
for bladder cancer (83). Lastly, S/MARs also appear to play a role in some 
pathologies. For example, deletions involving the breast-cancer susceptibility 
genes BRCA 1 and BRCA2 occur at S/MARs. Additionally, AT islands linked to 
FRA16B site (associated with leukemia) are susceptible to be expanded, which 
appears to strengthen their attachment to the nuclear matrix (35). Further 
studies are necessary to understand the reasons and extent of nuclear matrix 
involvement in pathologic processes, potentially aiding in the early detection 
and effective treatment of these diseases. 
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PERSPECTIVE OF THE NUCLEAR MATRIX  
 
 The study of the nuclear matrix has come a long way since Berezney 
and Coffey proposed its existence in 1974. Since then, our understanding of 
how nuclear architecture contributes to different cellular processes has greatly 
increased.  It is now more apparent that the functional relevance of the nuclear 
matrix is very complex, and even though well documented it has yet to be fully 
accepted.
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CHAPTER II 
THE IDENTIFICATION AND EXPRESSION PROFILE OF THE Drosophila 
HOMOLOGUE TO THE HUMAN SCAFFOLD ATTACHMENT FACTOR B 
(SAFB) 
 
 
INTRODUCTION 
 
 Nuclear processes in the eukaryotic cell occur on DNA organized into 
chromatin domains by the nuclear matrix. Evidence of the importance of the 
nuclear matrix is seen in a number of diseases associated with defects in this 
structure (81, 82). To understand the role of the nuclear matrix in cellular 
processes, it is first necessary to study its components. Several nuclear matrix 
proteins, mostly from mammalian cells, have been characterized over the years. 
Many of these proteins have been biochemically described, but their function in 
vivo is still relatively unclear. It has been shown that some of these proteins are 
important for gene expression, DNA replication and RNA splicing. However, 
many of the proposed models require more critical experimental tests. 
 Human Scaffold Attachment Factor B (SAFB) is a multifunctional nuclear 
matrix protein (84) implicated in numerous cellular processes which include 
chromatin organization, transcriptional regulation, RNA splicing and the stress 
response. Human SAFB was originally identified based on its ability to bind to 
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S/MARs in vitro (85). Subsequently, it was characterized as a protein binding to 
an Estrogen Response Element (ERE), which is adjacent to the TATA box in the 
promoter of the heat shock protein hsp27—referred to as the hsp27 ERE TATA 
(HET) (84). Weighardt and colleagues (86) identified SAFB/HET in a yeast two 
hybrid screen using hnRNP A1 as bait, introducing the name HAP (hnRNP A1 
associated protein). Therefore, SAFB, HET and HAP are identical.  
 In humans there are two SAFB genes, SAFB1 and SAFB2. These genes 
have 74% similarity at the amino acid level. SAFB1 and SAFB2 are encoded by 
two different genes arranged in a divergent configuration at position 19p13.3. 
These genes are separated by a 490 bp GC-rich intergenic region that functions 
as a bidirectional promoter (87). The Human SAFB family members are 
ubiquitously expressed. SAFB1 and SAFB2 are expressed in most tissues, with 
a very high expression in the brain, which suggests the importance of these 
proteins in the cell (87). 
 Sequence analysis of the Human SAFBs reveals highly charged regions, 
with both the N- and C- terminus being basic and the central region acidic (85). 
The primary structure of SAFB reflects the multiple functions carried on within 
the cell. The N-terminus contains a SAF-Box, also called SAP (SAF-A/B, Acinus, 
PIAS) domain. The SAF-Box is a homeodomain-like DNA-binding motif that 
interacts specifically with S/MARs and is often found in proteins involved in 
chromatin organization and RNA-processing. SAF boxes are present in 
organisms as diverse as yeast, plants and mammals, but are not present in 
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prokaryotes (88). The central region of the proteins contains an RNA recognition 
motif (RRM). In fact, human SAFBs are heterogeneous nuclear 
ribonucleoproteins (hnRNP) that associate with nascent RNA and are important 
for processing (86). The RRM domain is flanked by S/K-R/E rich domains, 
shown to be important for SAFB1 interactions with other hnRNP proteins and SR 
kinases (89). The C-terminal domain contains a Gly-rich region involved in 
protein-protein interactions (90).   
 In Drosophila, the importance of the nuclear matrix in different cell 
functions has been described but is not fully understood. Several S/MAR 
sequences and nuclear matrix proteins have been described in flies where they 
have been linked to developmentally regulated genes as well as insulators (50, 
53, 54). However, less is known about the different nuclear matrix proteins, and 
until now there were no studies about Scaffold Attachment factors A or B either 
in Drosophila or in other model organisms. 
 Here, I report the discovery and characterization of the Drosophila 
homologue of SAFB. This work will help us extend the knowledge of nuclear 
matrix and gain insight into the different functions of nuclear matrix proteins. I 
describe multiple characteristics of the sequence of the CG6995 gene, which I 
found to be the only Drosophila homologue to human SAFB. I also report the 
finding of a new splice form of CG6995 that is lacking the RRM domain, 
potentially important in deciphering the different roles associated with SAFB. 
CG6995 is ubiquitously expressed throughout development in various tissues, 
 37 
similar to the human safb gene family. Collectively, the structure and expression 
of CG6995 clearly establish the gene as the only Drosophila homologue of 
human SAFB. 
 
RESULTS AND DISCUSSION    
 
CG6995 sequence is homologous to human SAFB1 and SAFB2   
 
 SAFB homologues are found in a variety of eukaryotic organisms such 
as mammals, fungi, arthropods, nematodes, and plants. Since SAFB is 
conserved among eukaryotes—seeming to play an important role in nuclear 
architecture and gene expression—I was curious as to whether Drosophila 
contains genes that are members of the safb family. Taking advantage of the 
high similarity in the DNA and RNA binding domain of human SAFBs, I analyzed 
the Drosophila genome using a BLAST search program to find predicted 
homologue sequences. I identified a single gene, CG6995, a 4904 bp sequence 
whose homology (37% identity) with the human SAFBs spans the length of the 
protein. Further computer analysis to scan for motifs in CG6995 (comparing with 
Prosite, PeroxiBase and Pfam libraries) showed that the predicted sequence of 
CG6995 contains a SAP domain in its N-terminus that shares 48.6% identity 
with human SAFB1 and 57.1% identity with human SAFB2. This SAP domain 
also has a high degree of identity with the SAP domain of other proteins in 
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various organisms, such as PARP in humans and KU70/KU80 in plants (88). 
Structurally, a multiple alignment of various SAP domains reveals two regions of 
conserved hydrophobic, polar and bulky amino acids, separated by a region that 
contains and invariant Glycine residues. 
 CG6995 also contains a central putative RNA Recognition Motif (RRM), a 
domain responsible for the RNA-binding property of many proteins, including 
human SAFB (90). The RRM domain has 68.4% identity with SAFB1 and 73.4% 
identity with SAFB2. Additionally, the C-terminus of CG6995 contains a 
Glutamate/Arginine (E/R)-rich domain followed by a Glycine-rich domain, like 
human SAFBs (Fig.13). E/R-rich regions are seen in a number of nuclear 
proteins, representing a common protein interaction domain. Both rich domains 
mediate interaction of Human SAFB1 with other proteins such as Sam68, T-
STAR and SAFB2 (67). This suggests that the Drosophila gene CG6995 is a 
homologue of human SAFB proteins, since it contains all of the domains that are 
characteristic of the safb family.  
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Fig. 13. A schematic representation of the Drosophila gene CG6995 and its 
human homologous. Drosophila CG6995 possesses the same structural 
features as human SAFB1 and SAFB2. Characterized domains (SAP, RRM) are 
shown, as well as K-, G-, R-, and E-rich regions. The percentage of identity 
between domains is indicated. 
 
 
 
 It is well established that human SAFB1 is phosphorylated in vivo (85), and 
it can be phosphorylated in vitro by CLK2 (91). In addition, it is known that 
proteins associated with the nuclear matrix are heavily phosphorylated (25, 28). 
To test whether the predicted Drosophila protein could be phosphorylated, I 
analyzed the amino acid sequence. The CG6995 predicted protein contains 
numerous Serine, Threonine and Tyrosine residues, which are capable of 
accepting phosphorylation modifications. Of all the residues of the predicted 
sequence of CG6995, 104 can be potentially phosphorylated based on the 
NetPhos 2.0 algorithm (92) and 51 by KinasePhos algorithm (93), using artificial 
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neural network methods to predicts phosphorylation sites. Nine of these amino 
acids correspond to sites that have been identified as phosphorylated in vivo 
and are reported in PhosphoPep database (94). Three of these positions, S487, 
S487 and S205, were identified as a possible phosphorylation substrate for the 
human CLK2 and human CSNK2B (http://scansite.mit.edu/) (Fig. 14). A number 
of potential phosphorylation sites have been identified for CG6995, but the 
effects of these or other posttranslational modifications are not known. The 
interaction of human SAFB with DNA, RNA and many different proteins, such as 
splicing regulators (67), protein kinases (89), RNA polymerase II (91) and 
nuclear hormone receptors (80) have been well described. It is possible that 
chemical modifications may affect SAFB’s ability to form different protein 
complexes, as well as have subnuclear localization depending on the cell-type 
or cell cycle stage.    
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Fig. 14. Potential phosphorylation sites in the CG6995 gene. Graphic illustration 
of potential phosphorylation sites as identified by the NetPhos 2.0 algorithm 
identification is shown. The height of the bar indicates probability for Serine 
(blue), Threonine (green) and Tyrosine (red) phosphorylation. Black squares 
indicate phosphorylation sites confirmed in PhosphoPep studies, along with the 
putative kinase responsible based on sequence consensus.  
 
 
 
 To further characterize the CG6995 sequence, I tested if the predicted 
protein is an intrinsically unstructured protein. Instrinsically Unstructured 
Proteins (IUPs) are characterized by the lack of stable tertiary structure when in 
solution (95, 96). It is known that a large portion of their sequences contain 
segments with large degree of repeated amino acids (95) consistent with the 
predicted sequence of CG6995. With the help of Dr Sarah Bondos, I used the 
PONDR VL-TX, DisEMBL, and IUPred programs to analyze unstructured 
residues of the sequence. Disorder was found to be significantly higher 
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throughout the sequence, with the SAP and RNA-binding domains having a 
more ordered structure (Fig. 15). This lack of structure is thought to provide 
some advantages, such as conformational flexibility to interact with multiple 
potential targets and to allow access to potential posttranslational modifications 
sites (96). Such is the case of chromatin remodelers, proteins involved in 
nucleosome re-positioning and modification, some of which harbor at least one 
intrinsic disorder region. It has been shown that such regions are directly involve 
in binding to naked or modified DNA, histones, and other chromatin-related 
factors (97). In agreement with this, many studies show that SAFB has the 
flexibility to bind to many different partners simultaneously, taking part in many 
cellular processes. 
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Fig. 15. CG6995 is predicted to be an intrinsically unstructured protein. (Top) 
Schematic representation of CG6995 showing the domains of the predicted 
protein. (Bottom) Alignment of the results from structural determination 
algorithms (red bars are PONDR VLXT, Blue bars DisEMBL, and Brown bars 
IUPred) showing extensive intrinsically disordered domains. The only predicted 
ordered domains are the SAP and RRM domains as seen by the average score 
(black line).  
 
 
 
CG6995 has two splice forms 
 
 Humans possess two safb genes, encoding two different proteins, each 
containing a SAP domain, an RNA binding domain and R/E and G-rich domains. 
Since Drosophila possesses a single safb-like gene, I sought to characterize its 
three reported mRNA splicing forms. Splice form CG6995-A has a length of 
4021 bp, CG6995-B is 3142 bp and CG6995-C is 3544 bp long. The predicted 
amino acid sequence of the CG6995-B form is the only one that possesses all 
the domains similar to human SAFB. Neither of the predicted sequences from 
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CG6995-A nor C have a SAP domain. In order to probe the existence of the 
CG6995 splice forms, I performed Reverse Transcriptase PCR, on RNA 
obtained from embryos, larvae and adults. By using primer set 2 and 4 (Fig. 16), 
I confirmed splice form CG6995-B, which codes for a predicted protein of 928 
amino acids that contains the same domains as the human SAFBs. Using these 
and an additional pair of primers (primers 3 and 4, Fig. 16), I was unable to 
obtain products corresponding to CG6995-A or CG6995-C, raising the possibility 
that these are artifacts inaccurately labeled as mature mRNA. In addition to 
these alternative splice forms, I identified an additional, smaller splice form, 
using adult fly cDNA and primers flanking the entire gene region. I subsequently 
named this form CG6995-D. This new splice form was cloned and confirmed by 
sequencing. CG6995-D form maintains the same reading frame as the CG6995-
B form, but lacks the RNA binding domain and the R/E rich domain. There is not 
previous information in humans or mice of a SAFB protein lacking the RNA-
binding domain and R/E rich domain, making this novel protein an important tool 
to understand the role of SAFB in the cell. Even though there is no evidence of a 
role of this small splice form, based on the human SAFB characteristics, such as 
the SAP domain binding to S/MAR sequences, the RRM domain binding RNA 
and the R/E rich domain interacting with RNA polymerase II and other hnRNP 
proteins, it is possible to hypothesize that the role of this predicted protein is to 
function merely as scaffold by solely binding S/MARS and organizing the 
chromatin but is not important in RNA splicing or transcription.  
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Fig. 16.  Schematic representation of the CG6995 gene products (top) and 
predicted proteins (bottom). CG6995 has three annotated mRNA species 
(A,B,C) at Flybase. Functional domains of the B form included SAP domain, 
RRM domain and regions rich in R/E, G and K. A novel D form was found in this 
study, which encodes a smaller RNA transcript and predicts a protein lacks the 
RRM domain and the R/E rich domain. Primers designed for this study are 
shown in red. 
 
 
 
Ubiquitous expression of CG6995 in Drosophila 
 
 As described above, it is known that the human SAFB proteins are 
ubiquitously expressed. SAFB1 and SAFB2 are expressed in adrenal glands, 
liver, heart, lung, pancreas, kidney, placenta, prostate, salivary glands, skeletal 
muscle, spleen, testis, thyroid, trachea and uterus (85). Additionally, SAFB1 and 
SAFB2 are highly expressed in the brain and central nervous system (87). To 
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determine if CG6995 is ubiquitously expressed in the fly, consistent with human 
SAFB expression, I tested whether its expression is restricted to a specific 
developmental stage or if it is expressed throughout the Drosophila life cycle. I 
performed Reverse transcriptase PCR (RT-PCR) using specific primers that 
allowed me to differentiate between the two splice forms. Both mRNA species 
were detected in all developmental stages at similar levels (Fig. 17).  
 
 
 
 
Fig. 17. CG6995 is expressed during all developmental stages. CG6995 mRNA 
expression was analyzed by RT-PCR. CG6995 mRNA is expressed in all life 
stages, and in soma (heads) and mixed soma/germ (bodies). RT-PCR analysis 
was performed using primer specific for the B splice form (Fig. 16 Primers 2 and 
4) and D splice form (Fig 16. Primers 2 and 5). 18S rRNA was used as internal 
control. 
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 I next searched for specific localization of CG6995 mRNA in different 
embryonic tissues by RNA in situ hybridization. I used a probe against the RRM 
binding domain to specifically differentiate the longer splice variant. There is no 
unique sequence that allows detection of the smaller splice form. Thus, I 
generated a probe against the entire CG6995 sequence to evaluate the 
expression of both mRNAs. In embryos, both probes showed that CG6995 
mRNA is maternally loaded into the egg, and is present during all developmental 
stages of the embryo (Fig. 18 A-F). It is clear that mRNA is present at higher 
levels in the central nervous system after germband extension (Fig. 18 D-H), in 
agreement with studies showing higher levels of human safb expression in the 
central nervous system (87). CG6995 expression continues through the larval 
stage, as seen in brain and imaginal tissue (Fig. 18 I-K). Additionally, whole 
mount in situ hybridization was performed in adult tissues, using the probe that 
hybridizes to the entire gene. In testis and ovaries, mRNA is found near the 
apical tip, appearing excluded from the stem cells, but induced in mitotically 
dividing germ cells (Fig. 18 L-M). In the testis, expression is evident in the 
cortically-located spermatocytes, but declines in more mature cells further away 
from the apical tip (Fig. 18 M). In the ovaries, expression is detected in stage 3 
germaria and continues along in each individual follicle. mRNA is present in the 
nurse cells and in the oocytes, which is consistent with the detection of mRNA in 
embryos prior to the beginning of zygotic transcription (Fig. 18 A and L).  
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Fig. 18. CG6995 expression during Drosophila development. A-H. Whole-mount 
in situ hybridizations of wild-type embryos were performed with a CG6995 
antisense RNA probe. A. Syncytial blastoderm embryos show a uniform 
distribution of maternally deposited CG6995 RNA. After maternal RNA 
diminishes, CG6995 mRNA persists in the cellularized blastoderm embryos (B), 
mid-cellularized blastoderm (C), gastrula (D), germ-band elongated (E) and 
retracted (F) embryos with higher mRNA expression in the nervous system. Late 
stage embryos show CG6995 mRNA accumulation in the brain (G) and the 
ventral nerve cord (H). Additionally, expression in third-instar larval brains (I), leg 
imaginal discs (J), and eye-antennal discs (K) are shown. CG6995 is expressed 
in nurse cells and oocytes in the female germline (M) and in developing 
spermatocytes in male germline (L). 
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CONCLUSIONS 
   
 Little is known about the mechanism of chromatin attachment to the 
nuclear substructure and its role in different cellular processes. To find out the 
role of the nuclear matrix in gene expression, I start by characterizing the 
Drosophila homologue of the human nuclear matrix protein, SAFB. I focused on 
SAFB due to its specificity in binding the S/MAR of genomic DNA and due to its 
involvement in multiple cellular processes, from gene regulation to mRNA 
processing. 
 Here, I report the first characterization of Drosophila SAFB (SAFB), which I 
identified to be the CG6995 gene. CG6995 encodes a putative protein 
containing a SAP domain, an RNA binding domain and Arginine/ Glutamine and 
Glycine rich domains. Additionally, I confirmed the existence of a full-length 
splice form (CG6995-B) and discovered a novel splice variant (CG6995-D) 
missing the RNA binding domain. Further, I showed that both splice forms are 
expressed in all developmental stages of Drosophila.  
 Taken together, these results suggest that CG6995 is the Drosophila SAFB 
based on the homology of the amino acid sequence, the conservation of 
characteristic domains and the mRNA expression pattern. In addition, it is 
important to emphasize that the detection of a new splice form of CG6995, 
lacking the RNA binding domain. This will help to understand the different roles 
of SAFB in the cell, by comparing first the localization of both proteins, SAFB-B 
and SAFB-D. Additionally, different biochemical experiments can be also be 
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performed to compared the DNA sequences and proteins to which the two splice 
forms bind. 
 
MATERIALS AND METHODS 
 
Fly stock and genetics 
 
 Flies were maintained on standard cornmeal, yeast, and sugar medium 
with Tegosept. Crosses were performed at 25°.  All fly lines used were from the 
Bloomington Drosophila Stock Center (http://flystocks.bio.indiana.edu). 
 
DNA constructs 
 
 Drosophila SAFB was amplified from genomic DNA using primers: 
5′CACCATGCCCGAGGCAGGAAAGAA 3′ and 5′GTAGCGCGACACCGGTC 3′. 
The PCR products were cloned into the pENTR/D-TOPO Gateway entry vector 
according to the manufacturer's instructions (Invitrogen) and the complete 
sequence was verified by DNA sequencing. 
 
Reverse transcription PCR 
 
Total RNA from embryos, third instar larvae, pupae and adult flies of wild-
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type flies was isolated by lysis and homogenization in TriZOL (Invitrogen), 
followed by chloroform/isopropanol extraction, ethanol precipitation, and 
resuspension in DEPC-water.  Reverse Transcription was done using 
SuperScript One-Step RT-PCR System from invitrogen. The primers use for RT-
PCR were  5′CACCATGCCCGAGGCAGGAAAGAA 3′ and 
5′GTAGCGCGACACCGGTC 3′ and amplification of the 18S rRNA using primers 
FWD: 5’ GACTACCAT GGTTGCAACGGG 3’ and RV: 5’ 
TTCGTCACTACCTCCCCGAG 3’ served as control. 
 
RNA In Situ hybridization 
 
 Unstaged (0-24 hour after egg deposition) embryos were collected from 
apple juice agar collection bottles, bleach dechorionated and fixed.  The in situ 
RNA  was carried out according to Ip et al. 1994. Ovaries, brains, imaginal discs, 
and testis were dissected from larvae or adults in Phosphate Buffered Saline 
and fixed for 15 min with 4% paraformaldehyde in phosphate-buffered saline. 
Digoxigenin-labeled antisense RNA probes directed at CG6995 were made by 
transcribing PCR amplified genomic DNA using primers 
5’ATGACCGAGGCAGGAAAGAA 3’ that includes the T7 RNA polymerase 
promoter (5'-TAA TAC GAC TCA CTA TAG GG-3’) at the 5’ end, and 
5’GTAGCGCGACACCGGTC 3’ that included a T3 RNA polymerase promoter 
(5’ATTAACCCTCACTAAAGGGA 3’) at the 5’ end. 
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CHAPTER III 
CELLULAR LOCALIZATION OF Drosophila SCAFFOLD ATTACHMENT 
FACTOR B (SAFB) 
 
 
INTRODUCTION 
 
 DNA replication, gene expression and RNA maturation are important 
functions of the eukaryotic nucleus. Such functions are linked to chromatin, and 
organized by a nuclear structure composed of protein and RNA called the 
nuclear matrix. Specific DNA sequences, called S/MARS, are tethered to the 
nuclear matrix via interactions with nuclear matrix proteins. S/MARS-nuclear 
protein complexes may be dynamic and heterogeneous in nature, with each 
complex different from others, a situation that adds another levels of complexity 
to the previously described cellular functions. How these dynamic complexes are 
regulated and their role in different cellular functions remain outstanding 
questions.  
 In studies of Scaffold Attachment Factor B (SAFB) there is a discrete 
connection between nuclear matrix, gene expression and RNA splicing. SAFB 
was independently identified as a SAR/MARs binding protein (85), as well as a 
protein retained in the nuclear matrix. It is also associated with transcription at 
the hsp27, binding and regulating its promoter (84), and as a factor required for 
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regulation of Estrogen-receptor-alpha transcriptional activity (80). Further studies 
have shown that human SAFB interacts with both RNA processing proteins (86) 
and with the C-terminal domain of RNA polymerase II (91) suggesting that it is 
part of a “transcriptosome” complex. Alternatively, SAFB is also found 
throughout the nucleoplasm and forming speckles, overlapping with the 
spliceosome complex. SAFB2 is also found in the cytoplasm. Despite all the 
information about human SAFB, there is not a clear understanding pertaining to 
its role in the nuclear matrix.   
 To confirmed the nuclear localization of S/MAR binding proteins and their 
association with the nuclear matrix, I studied the cellular localization of 
Drosophila SAFB protein using SAFB-GFP fusion proteins. I found that 
Drosophila SAFB is a nuclear protein that is found in three different 
compartments, similar to human SAFB and consistent with its potential role in 
gene expression and RNA splicing. Drosophila SAFB is found i) in the nuclear 
matrix, possible forming a web-like structure in salivary glands ii) throughout the 
nucleus and iii) in speckles. This distribution is not due to its DNA binding 
domain.  
 To further describe SAFB association to S/MAR sequences, I examined 
the distribution of SAFB along chromosomes. I show here that Drosophila SAFB 
binds to discrete sites on polytene chromosomes, mostly overlapping with RNA 
polymerase II. Association to these specific sites mostly depends on RNA 
binding, although some of the other SAFB localization sites depends solely on 
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DNA binding activity.  
 
RESULTS AND DISCUSSION 
 
Drosophila SAFB is a component of the nuclear matrix 
 
 Renz et al. (85) first described SAFB as a S/MARs binding protein and 
contrary to what was expected, they failed to detect the protein in the nuclear 
matrix after biochemical fractionation. Later, Oesterreich et al. (84), described 
human SAFB as a protein that binds to HSP27 promoter, but most importantly, it 
was detected in the nuclear matrix fraction. Therefore it is still unclear whether or 
not SAFB was found at the nuclear matrix. To determine if Drosophila SAFB is a 
component of the nuclear matrix, I performed biochemical extraction of the 
nuclear matrix by removing histones, soluble proteins and DNA from S2 cells. 
Since there are no antibodies against Drosophila SAFB, and the antibodies 
raised against the human protein did not show any cross reactivity (data not 
shown), I made constructs of the entire genomic fragment of safb (SAFB-FL) 
containing an N-terminal and C-terminal GFP-tag under the control of an 
ubiquitously expressed promoter (Act5C) to study localization of the protein in 
S2 cells (Fig. 19). I used both GFP tag versions, N- and C- terminus, so we can 
see that the SAFB distribution is not due to the position of the tag. Additionally 
GFP tags have been used in many studies to characterize the distribution of 
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different proteins.   
 
 
 
 
Fig.19. Drosophila SAFB constructs. Schematic representation of full-length 
genomic fragment (FL), a genomic fragment lacking the DNA binding domain 
(SAP-less) and cDNA constructs (SAFB-B form, SAFB- D form) used in this 
study. Represented here are the constructs containing an N-terminal GFP fusion 
that were also generated. 
 
 
 
 S2 cells were transfected using a GFP-SAFB-FL construct (Fig. 19) and 
allowed to express for 3 days before extraction with high salt (2M NaCl) and 
DNAseI. S2 cells were placed onto slides and nuclear matrix extraction was 
done in situ following protocols from Pathak et al. (55). These preparations were 
stained with antibodies against GFP and histone H3. Treatment of the cells 
under high salt conditions removes soluble protein and allows retention of 
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nuclear matrix-associated proteins and nucleic acids (16). As expected from the 
human homologue, GFP-SAFB-FL was retained in the nuclear matrix 
preparations, while H3 is not known to be associated with the nuclear matrix (98) 
but it is with the chromatin and thus serves as positive control for the extraction 
(Fig. 20). Both GFP-SAFB-FL and H3 are present in the cells prior to extraction. 
This results  support the data obtained by Oesterreich,1997, when SAFB was 
found in the nuclear matrix, after biochemical fractionation. To analyze if DNA 
binding activity mediates the association of SAFB with the nuclear matrix, I 
made a similar construct in which the safb genomic sequence is lacking its DNA 
binding domain (Fig. 19 SAP-less-GFP-SAFB). After extracting the nuclear 
matrix from S2 cells that express this construct, the truncated protein is still 
retained in the nuclear matrix preparations (Fig. 20). These data clearly show 
that Drosophila SAFB is part of the nuclear matrix and its SAP-domain is not 
necessary for this association. Keeping in mind these results, and that human 
SAFB is a nuclear matrix protein that contains a SAP domain, which binds to 
S/MAR sequences specifically, I hypothesize that Drosophila SAFB DNA binding 
activity is not necessary for nuclear matrix retention but instead it is the result of 
protein-protein interaction. However, I cannot exclude the possibility of the 
existence of additional, uncharacterized DNA binding domains in SAFB. 
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Fig. 20. Drosophila SAFB is associated with the nuclear matrix. The nuclear 
matrix was prepared from S2 cells on a slide and used for immunofluorescence 
using antibodies against GFP and Histone H3. The upper panels show nuclear 
matrix obtained from cells expressing full length SAFB protein. The lower panel 
shows cells expressing a SAFB truncated protein, lacking the SAP DNA-binding 
domain. In both cases SAFB is retained in the nucleus while both DNA and 
histones are removed entirely. 
 
 
 
SAFB is found in two nuclear compartments in the cell 
 
 Human SAFB1 is broadly localized in the nucleus but also in a punctae 
pattern which overlaps with proteins in RNA splicing complexes (91). To 
determine whether Drosophila SAFB is also found in speckles, I used the same 
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GFP constructs to analyze intracellular localization of Drosophila SAFB by 
immunofluorescent microscopy of S2 cells. These experiments clearly 
demonstrate that SAFB is located in the nucleus in two different compartments. 
First, SAFB is located throughout the nucleus, including the heterochromatin, but 
excluded from the nucleolus (Fig. 21), suggesting that SAFB localized to highly 
transcribed and to silence regions of the chromatin but not to the rRNA genes 
localized in the nucleolus.  In addition, SAFB does not overlap with the nuclear 
pore staining (Fig 22A), indicating that SAFB is not part of the nuclear envelope. 
Second, GFP-SAFB forms more intense foci, which do not correspond to any 
obvious DAPI staining (Fig 21), in agreement with the localization of human 
SAFB on foci that contains RNA splicing complexes (67). In Drosophila, these 
foci do not overlap with the elongating RNA Polymerase II of with CTCF, a 
protein with insulator activity (data not shown). However colocalization of 
Drosophila SAFB with splicing complexes still needs to be tested. Over-
expression of SAFB in human cells has proven to be difficult since these cells 
have a reduced S-phase and present multinuclearity (99). However, I did not 
observe any multinuclearity in the cell as a result of Drosophila SAFB over-
expression. 
 These SAFB foci seem to increase in size whenever the over-expressed 
GFP-SAFB was lacking the SAP domain (Fig 21E). I hypothesize that these 
bigger foci are the result of the protein not being able to bind to DNA since is 
lacking the SAP domain, causing a higher concentration of SAFB aggregating 
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into foci. When I over-expressed a tagged version of the B splice form, the 
protein was also found in the nuclei forming a speckled pattern with the intensity 
and number of foci increasing (Fig 21D). The simplest explanation for this result 
is that since the plasmid containing the sequence for the SAFB B form is smaller 
the efficiency for its transfection is higher. Additionally, transcription of an 
endogenous gene in cell culture depends on the size of the vector in which is 
found (100). It is possible that the B form of SAFB needs other proteins that are 
not over-expressed, such as the SAFB protein lacking the RRM domain, in order 
to have normal nuclear localization. Unfortunately I have not been able to 
express the splice form D, which lacks the RNA binding domain. Possibly the 
sequence contains a point mutation causing instability of the protein. 
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Fig. 21. The Drosophila SAFB fusion protein is found in the nucleoplasm and 
forming speckles in S2 cells. A. C-terminal GFP tagged SAFB protein (SAFB-
GFP) is localized to the nucleoplasm, but is excluded from the nucleolus. B. 
Confocal image of a SAFB-GFP expressing cell, showing focal accumulation. C. 
N-terminal GFP tagged SAFB (GFP-SAFB) protein distribution is identical to 
SAFB-GFP. D. Distribution of the B splice form of GFP-SAFB. General 
nucleoplasmic staining is shown, with more and brighter foci. E.  GFP-SAFB 
protein lacking DNA binding domain is similarly distributed as the full-length 
protein.  
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 I wanted to confirm that the localization I observed in S2 cells was general, 
and not a property specific to the cell type. To do so I created flies that contain 
GFP-tagged full length SAFB under control of the Upstream Activation 
Sequences. After driving the expression of the tagged protein with a ubiquitously 
expressed transcription activator (actin5c-gal4), I observed that Drosophila 
SAFB is present throughout the nucleus and found in speckles in embryonic 
cells (Fig 22B) and in neuroblasts (Fig 22C), similar to results seen in S2 cells, 
so this confirms that the localization of SAFB in the two different nuclear 
compartments—throughout the nucleus and in speckles—is a general 
distribution find in diverse type of cells. I was able to analyze the localization of 
the tagged protein in mitotic chromosomes of diploid cells from larval brains. I 
did not observed an obvious binding of SAFB to the chromosomes, maybe in 
part due to the size of the mitotic chromosomes or the concentration of the 
SAFB protein interacting with the DNA. However, Drosophila SAFB is observed 
around the mitotic chromosomes spreads, where the dispersion of some of the 
nucleoplasmid proteins during the cell cycle mediated nuclear envelope 
breakdown is observed (Fig 22D). Unfortunately, I am unable to conclude that 
Drosophila SAFB is part of the mitotic chromosome scaffold, since an extraction 
with high salt is necessary. 
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Fig. 22. Drosophila SAFB fusion protein is found in the nucleoplasm and forming 
speckles. A. Immunofluorescent detection of GFP-SAFB does not show overlap 
with the nuclear pore complex in S2 cells. Immunofluorescent staining reveals 
general and focal localization of ectopic GFP-SAFB in embryonic nuclei (B) and 
larval neuroblast nuclei (C). D. GFP-SAFB is not associated with mitotic 
chromosomes of diploid neuroblast cells. 
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SAFB forms a threadlike network in large polytene nuclei 
 
 Further experiments were carried out to determine how SAFB protein is 
distributed in different cell types. To do this, I took advantage of the big size of 
the polytene nuclei of Drosophila salivary glands and examined the localization 
of GFP-SAFB, the full-length fragment and the splice form B. The SAFB protein 
from the SAFB-FL construct was forming a continuous, threadlike network in the 
periphery, which may represent the  “biochemically-defined” matrix in these 
nuclei, as well as some localization with DNA bands (Fig. 23A). This structure 
had not been observed in our previous or other studies, possibly due to 
limitations in the resolution of smaller diploid nuclei. In contrast, our results 
obtained using SAFB splice form B did not show a thread-like network. Instead, 
only localization of the protein to the DNA was seen (Fig 23B). While the exact 
reason of the localization of the B form to DNA and not forming threadlike 
network is not known, it may be the result of over-expression of just one safb 
splice form and not the other. It is possible that the splice form lacking the RRM 
is either the only form present in the threadlike network or is necessary for the B 
form to be retained in such structure. 
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Fig. 23. Distribution of Drosophila SAFB in larval salivary gland nuclei. A. Full 
length GFP-SAFB forms a threadlike continua in salivary nuclei. B. Nuclear 
distribution of the GFP-SAFB protein from the B splice form DNA sequence does 
not form a threadlike frame, instead being bound to the DNA. DNA was stained 
with DAPI. 
 
 
 
SAFB is localized on discrete bands on polytene chromosomes 
 
 The premise that if Drosophila SAFB is important for gene expression and 
chromatin organization then it should bind to DNA. Additionally, the fact that 
Drosophila SAFB contains a DNA-binding domain along with the results of its 
nuclear localization in S2 cells and whole mount salivary glands, prompted me to 
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examine any potential DNA binding specificity of SAFB. I analyzed the 
distribution of GFP-SAFB on polytene chromosomes using anti-GFP antibodies. 
Detection of the fluorescent signal revealed that GFP-SAFB protein is localized 
to discrete bands of the chromosomes, suggesting distribution to specific DNA 
elements in the genome (Fig. 24A). There was some focal localization of protein 
in the heterochromatic chromocenter, and no detectable signal in the nucleolus 
(Fig. 24B). Distribution of the B splice form of SAFB is also localized to discrete 
bands, but with all the bands presenting similar intensity (Fig. 24C). Because it 
has been shown that human SAFB interacts with the carboxyl-terminal domain 
of RNA polymerase II (91) and with repressed genes (84), I tested by 
immunofluorescence whether Drosophila SAFB co-localizes with elongating 
RNAPII on polytene chromosomes. I observed that a significant number of 
bands overlap, although there are some bands that exhibited just one epitope. In 
fact, for some of the non-overlapping bands, SAFB signal was more intense 
(Fig. 24D), suggesting localization of many molecules SAFB to sites where there 
is not transcription. The SAFB-RNAPII overlap distribution suggested that 
Drosophila SAFB localizes to the chromosomes mainly at sites of transcription, 
possibly by directly binding to the DNA via its SAP domain, to the RNAPII 
through R/E rich domain or to nascent RNA through its RRM domain. In 
contrast, the bright bands of GFP that do not overlap with RNAPII suggest that 
SAFB localizes to non-transcribing regions, but possibly to S/MAR sequences 
through the SAP-domain in order to organized the chromatin into loops.  
 67 
 
Fig. 24. Distribution of SAFB on polytene chromosomes. A. Squashed polytene 
chromosomes showing association of SAFB with specific bands. The left panel 
shows distribution of SAFB at the tip of the X chromosome. B. Foci localization 
of GFP-SAFB in the chromocenter of salivary glands chromosomes 
(arrowhead). In addition, no localization of GFP-SAFB was found in the 
nucleolus (arrows). C. Comparison of the distribution of GFP-SAFB expressed 
from a genomic DNA fragment to splice form B GFP-SAFB. Stars are showing 
the tip of chromosome 3L D. Immunodetection of SAFB protein and RNA 
Polymerase II (Ser2-PO4) showing broad overlap of the two proteins, as well as 
non-overlapping bands (starts). DNA is stained with DAPI. 
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 The above experiment suggests that SAFB localization may be due to 
directed binding to the DNA via SAP domain, by RNA binding via RRM domain 
or by protein-protein interaction. Taking advantage of the SAP-less SAFB 
construct, I investigated the localization of this SAFB truncation protein on 
polytene chromosomes to discard that the SAP domain is important for 
colocalization of SAFB with RNAPII. The distribution of the truncated SAFB 
version presents a very broad but precise localization and looked similar to that 
seen for full length SAFB, although there were obvious differences in the 
intensity of some of the bands, specifically the most intense were mitigated (Fig 
25A and B). 
 That SAFB is still associated to the chromosomes in the absence of its 
DNA binding domain implies that SAFB localizes to specific sequences not 
through its SAP domain, but rather through an uncharacterized DNA binding 
domain, or by protein-protein or RNA-protein interaction. Human and Drosophila 
SAFB both contain a putative RNA binding motif and a protein-protein interaction 
domain. To establish if SAFB localization depends on RNA, I treated polytene 
nuclei with RNase before immunodetection to remove proteins whose binding is 
RNA-dependent. Thus, if Drosophila SAFB localizes to the DNA in a RNA-
dependent fashion, it will be lost from the chromosomes upon RNase treatment.  
 In fact, after RNase treatment, most bands of SAFB were lost from the 
chromosomes. This suggests that most Drosophila SAFB recruitment is through 
RNA binding activity, either direct binding or through RNA-dependent protein-
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protein interaction. The majority of bands that were left after RNase treatment 
did not overlap with RNAPII (Fig. 25C), suggesting that at these bands the 
recruitment to the chromosomes is RNA-independent. Since there are still some 
bands left after RNAse treatment it is possible that the localization of SAFB to 
this bands is due to direct binding to DNA via its SAP domain. To determine if 
Drosophila SAFB localization is associated with its DNA binding domain, I 
RNase treated polytene nuclei in flies expressing the SAFB protein lacking the 
SAP domain. I observed that nearly all SAFB was lost from chromosomes (Fig 
25D). There are few bands in which it seems that there is still some SAFB 
present but since they colocalized with bright bands of RNAPII, it is probably that 
this residual protein is due to incomplete RNA degradation.  Based on human 
SAFB, we can hypothesize that localization to the chromosomes is also due to 
DNA directed binding. Recently, the Oesterreich group identified binding sites for 
human SAFB1 and SAFB2 in 541 promoters of many genes some of which are 
involved in regulation of immune system and apoptosis (101). However, it is not 
possible to discriminate whether these interactions occur by direct binding to 
DNA or is RNA-dependent. In here, I showed that SAFB is localized to specific 
bands in polytene chromosomes. Additionally, I showed that SAFB is found 
mainly colocalizing with elongating RNAPII and that this distribution is RNA-
dependent suggesting a role in gene expression. SAFB is also found in bands 
where RNAPII is not present. In these bands localization of SAFB is SAP-
dependent, suggesting a role in chromatin organization.      
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Fig. 25. Drosophila SAFB distribution on polytene chromosomes is DNA and 
RNA- dependent. A. Association of SAFB with specific bands in polytene 
chromosomes. B. Squashed polytene chromosomes showing the association of 
SAP-less SAFB truncated protein with specific bands. C. Immunodetection of 
SAFB after RNase treatment shows a decrease in the number of GFP-SAFB 
associated bands. D Immunodetection of SAP-less SAFB after RNase treatment 
shows no localization of the truncated protein in the polytene chromosomes. 
Insets in B-D are whole mount nuclei comparing distribution of SAFB to the DNA 
in B to punctuated distribution of the protein in the RNAse treated nuclei. DNA is 
stained with DAPI. 
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Heat-shock-induced gene expression alter Drosophila SAFB localization 
 
 Human SAFB has been described as a heterogeneous nuclear 
ribonucleoprotein (hnRNP), a member of a class of proteins that binds to 
newly synthesized RNA (86). Additionally, I have shown that the Drosophila 
homologue is mostly recruited to polytene chromosomes colocalizing with 
Polymerase II and in a RNA-dependent fashion. To confirm that Drosophila 
SAFB is recruited to sites of newly synthesized RNA, I induced gene expression 
of the heat shock genes, localized in the 87A-C band, by heat shock and 
compared binding of the protein before and after 15 min of the induction. Prior to 
the heat shock, there is no detectable protein in the cytological band 87A-C (Fig. 
26A). However, after heat shock, Drosophila SAFB binds to the puffs created at 
decondensed chromatin that is being highly expressed (Fig. 26B). To further 
confirm the RNA- dependent localizaton, this new protein distribution is not 
dependent on SAFB DNA binding domain, since a fusion protein lacking the 
SAP-domain is also recruited to the puffs upon heat shock (Fig. 26C).  
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Fig. 26. Drosophila SAFB is redistributed to heat shock loci on polytene 
chromosomes after heat shock. Redistribution of GFP-SAFB at polytene bands 
87A and 87C, before (A) and after (B) heat shock induction. C. Immunodetection 
of SAP-less SAFB shows localization of the truncated protein in the heat shock 
loci after induction. DNA is stained with DAPI. 
 
 
CONCLUSIONS 
  
  Human SAFB is a nuclear matrix protein that was first described as a 
protein that specifically binds to S/MAR sequences (85). Further studies showed 
that human SAFB does not bind just to DNA but also to RNA as well as other 
proteins (67, 91, 102), and its broad distribution in the cell is a clear display of 
that. I have shown that Drosophila SAFB is present in three different 
compartments of the cell, similar to what is seen in human cells. SAFB is 
localized in the nuclear matrix, throughout the nucleus and in speckles. At the 
same time these results support the use of Drosophila as a model to study 
SAFB proteins. Furthermore, I have shown that Drosophila SAFB is distributed 
along polytene chromosomes with this localization dependent on the SAP 
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domain and RNA. However how Drosophila SAFB forms part of the nuclear 
matrix protein, and an explanation of its DNA and RNA binding specificities to 
coordinate gene expression and/or chromatin organization, is still unknown. 
Further analysis of those details will be essential in understanding the role of the 
nuclear matrix in the cell. 
 
MATERIALS AND METHODS 
 
DNA constructs 
  
 Drosophila SAFB was amplified from wild-type genomic DNA using 
Polymerase Chain Reaction and the PCR extended system of 5PRIME with 
Primer 1: 5’ CACCATGCCCGAGGCAGGAAAGAA 3’ and Primer 6: 5’ 
GTAGCGCGACACCGGTC 3’.  The SAP-less form was also amplified using the 
PCR extended system of 5PRIME and the primers: 5‘ CACCATGAG 
AGCTGAAGGGCTCGACCC 3’    and Primer 6: 5’ GTAGCGCGACACCGGTC 
3’.  The PCR products were cloned into the pENTR/D-TOPO Gateway entry 
vector according to the manufacturer's instructions (Invitrogen) and the complete 
sequence was verified by DNA sequencing. SAFB sequence was then excised 
from pEntr/D-TOPO and ligated into pAWG, pAGW, pTW, pTGW and pTWG, 
from the Drosophila gateway collection, using the LR clonase reaction according 
to the manufacturer's instruction (Invitrogen). 
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Drosophila stocks 
 
 Flies were maintained on standard cornmeal, yeast, and sugar medium 
with Tegosept. Crosses were performed at 25°.  The wild-type was yellow1 
white67c23. The gal4 drivers used in these studies were: 1. SGS (6870):  w[1118]; 
P{w[+mC]=Sgs3-GAL4.PD}TP1  and  2.  Act (4414): y[1] w[*]; P{w[+mC]=Act5C-
GAL4}25FO1/CyO, y[+]. All fly lines are available from the Bloomington 
Drosophila Stock Center (http://flystocks.bio.indiana.edu). 
 
Reverse transcription PCR 
  
 Total RNA from adult flies of wild-type flies was isolated by lysis and 
homogenization in TRIzol (Invitrogen), followed by chloroform/isopropanol 
extraction, ethanol precipitation, and resuspension in DEPC-water.  Reverse 
Transcription was done using SuperScript One-Step RT-PCR System from 
invitrogen. 
 
S2 cells transfection 
 
 S2 Schneider cells were grown in Schneider medium (GIBCO), 10% Heat 
inactivated fetal bovina serum (GIBCO) and 50 µg/ml penicillin and streptomycin 
(GIBCO). S2 cells were transiently transfected by the calcium phosphate 
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precipitation method, with pAWG, pAGW containing either Full length SAFB 
sequence or the SAP-less sequence incubated for 3 days, and analyzed by 
Immunofluorescence or nuclear matrix extraction.  
 
Nuclear matrix extraction 
  
 Cells were washed twice in PBS and extracted in cytoskeleton (CSK) buffer 
(100 mM NaCl, 300 mM sucrose, 10 mM PIPES pH 6.8, 3 mM MgCl2, 1 mM 
PMSF, 0.5% Triton X-100 and RNase inhibitor 20unit/ml). After 10 min on ice, 
the buffer was completely removed by aspiration.  Further extractions were 
carried out by adding Extraction buffer (250 mM ammonium sulfate, 300 mM 
sucrose, 10 mM Pipes, pH 6.8, 3 mM MgCl2, 0.5% Triton X-100, 1 mM PMSF 
and ribonuclease inhibitor 20 units/ml) for 5 min at 4 C. After removing the 
extraction buffer, Digestion buffer was added (50 mM NaCl, 300 mM sucrose, 10 
mM Pipes pH 6.8, 3 mM MgCl2, 0.5% Triton X-100, 1 mM PMSF ribonuclease 
inhibitor 20 units/ml, and RNase-free DNase 200-500 units/ml) and incubated for 
60 min at room temperature.  The digestion was terminated by removing the 
buffer and adding extraction buffer for 5 min at 4C. The slides were then 
processed for immunofluorescence. 
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Polytene chromosomes squashes 
 
 Polytene chromosome squashes were performed as previously described. 
(103). Heat shock procedure was done for 15 min following at 37 C (104).  
Squashes were then used for immunofluorescence staining.  
 For RNase treatments of the whole salivary nuclei, glands were dissected 
in PBS and half of them were incubated in TBS (10 mM Tris-HCl, pH 7.15, and 
150 mM NaCl), and the other half were incubated in TBS plus 50 µg/ml RNase A 
for 45 min at room temperature. The glands were transferred to TBS/0.05% 
Tween 20 for 5 min and fixed in formaldehyde fixative solution (PBS, 3.7% 
formaldehyde, 1% triton 100X). RNase treatments of the squashed salivary 
glands were done as described previously (105). Briefly, Salivary glands were 
dissected in PBS and then incubated 2min in PBS + 0.1% triton X-100, then to 
PBS + 0.5 mg/ml RNAse A 8min. Fixation and squashing were done as 
previously described. 
 
Immunofluorescence and microscopy 
 
 For S2 cells and nuclear matrix, immunofluorecence was carried out as 
previously described (106). Briefly, cells were fixed with 4% paraformaldehyde at 
37C for 30 min, while the nuclear matrices were fixed with 2% paraformaldehyde 
at room temperature for 15 min. Fixed cells were washed extensively, 
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permeabilized in 0.2 triton x-100 for 10 min, blocked with bovine serum albumin 
for 30 min, and incubated with primary antibody at 4°C overnight. Primary 
antibodies used were: antiGFP (Santa Cruz) 1:200, anti-Nuclear Pore Complex 
protein (Covance) 1:200, anti RNA Polymerase II (Ser2-PO4) (Abcam) 1:200 
and anti Histone H3 (Upstate). The incubation was followed by secondary 
antibody. Secondary antibodies used were: FITC-conjugated anti-rabbit IgG goat 
antiserum and FITC-conjugated anti-mouse IgG goat antiserum (Jackson 
Immunoresearch), TRITC-conjugated anti-mouse IgG goat antibodies and 
TRITC-conjugated anti-mouse IgG goat antibodies (Jackson Immunoresearch). 
All secondaries were used at 1:200 dilution. DAPI (1ng/mL) was routinely added 
to Vectashield (Vector labs) as a mounting medium for visualization of DNA.   
 For Polytene chromosome squashes, the slides were washed in PBST (1X 
PBS and 0.1% Tween 20) and antibodies were added, in PBST with 0.1% - 
0.5% BSA and allowed them to incubated overnight at 4°C. Then, slides were 
washed in PBST and were treated with the appropriate secondary antibody in 
PBST for 1.5 h at Room temperature. Slides were then washed in PBST, and 
stained with DAPI (1ng/mL), which was added to Vectashield (Vector labs) as 
mounting medium for visualization of DNA.   
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CHAPTER IV 
CREATION AND CHARACTERIZATION OF THE Drosophila SAFB 
KNOCKOUT ALLELE 
 
 
INTRODUCTION 
 
 Since the nuclear matrix was first described over 50 years ago, its 
structure and functions have been intensively studied. It is currently known that 
the nuclear matrix confers spatial and temporal organization of DNA replication, 
transcription and RNA splicing processes, and is associated with numerous 
enzymes and transcriptional factors. As a result, any changes in gene 
expression patterns, or in the timing of replication may, in part, result from a 
defect of the nuclear matrix. Therefore, the roles that nuclear matrix 
modifications play in different pathologies are being extensively studied.  
 Until now, aberrant nuclear matrix DNA attachment and/or mutation of 
matrix proteins have been associated with various genetic pathologies and 
inherited cancer syndromes (81, 107). Additionally, reports from different 
laboratories have described differences in expression levels of nuclear matrix 
proteins and their relation to the incidence of various tumors. For instance, 
bladder cancer development has been associated with the expression of the 
nuclear matrix protein, BLCA-4 (82). 
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 Studies have suggested that human Scaffold Attachment Factor B 
(SAFB), a nuclear matrix protein, may be an important player in breast cancer 
development. SAFB was first identified in a screen for protein binding to the 
promoter of the small heat shock protein hsp27. HSP27 enhances growth and 
drug resistance in breast cancer cells (84). Later, human SAFB1 was shown to 
be a co-repressor of Estrogen receptor a (ERa) by directly binding to ERa and 
inhibiting its transcriptional activity (87, 90). In addition, SAB1 mutations have 
been identified in breast cancer cell lines as well as in breast tumor tissue (108). 
Since originally identified, many studies have been conducted to characterize 
SAFB and determine its multiple roles in cellular processes.  
 Consequently with the variety of functions associated with human 
SAFB—interaction with DNA sequences, splicing factors (90, 91, 102, 109), 
polymerase II (91), and nuclear receptors (109)—it is clear that this scaffold 
protein is potentially involved in processes such as cell growth, apoptosis and 
the stress response (110-112).  
 Although numerous studies have characterized the SAFB1 protein in 
human cells, the diversity of its involvement in cellular processes and the 
existence of SAFB2 make it difficult to predict the physiological role of SAFB in 
vivo. The Oesterreich group (113) generated the only SAFB1 knockout mouse 
line. The majority of the homozygous SAFB1 knockout mice showed prenatal 
and neonatal lethality, attributed to defects in lung maturation and in the 
hematopoietic system. The SAFB1 knockout adults showed growth retardation 
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and defects in their reproductive organs. Despite these data, the exact reason 
for the phenotypes in mice lacking SAFB1 is unknown, and they raise additional 
questions regarding the differences between SAFB1 and SAFB2 and how their 
roles overlap. 
 In order to evaluate the role of SAFB in the nucleus and to gain insight 
into its molecular mechanism, I took advantage of the model organism 
Drosophila melanogaster. I used Drosophila because of the availability of a 
variety of sophisticated genetic and molecular tools, as wells as the fact that 
many of proteins and nuclear processes are evolutionarily conserved with 
respect to humans. Most important is the fact that Drosophila possesses a 
unique safb gene making it an ideal model for the study of SAFB. I describe here 
the creation of a fly lacking SAFB protein and characterized the SAFB knockout 
phenotype. Deletion of the safb by gene targeting ends-out in flies causes 
embryonic lethality.  However, knockdown of SAFB by RNA interference (RNAi) 
in Drosophila S2 cells and whole animals did not show any effect. Thus, more 
work is needed to find the exact nature of the knockout phenotype and to define 
the exact role of SAFB in chromatin architecture and transcriptional regulation.  
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RESULTS AND DISCUSSION 
 
RNAi targeting of Drosophila SAFB in whole flies and S2  
 
 Revealing the biological role of Drosophila SAFB is an important step in 
understanding the role of nuclear matrix in different cellular processes. To 
further investigate the relationship of SAFB with chromatin organization and its 
role in gene transcription and RNA maturation, I employed RNA interference 
(RNAi) to degrade Drosophila safb transcripts to attempt to reduce SAFB 
function. I cloned a sequence from the sixth exon of the SAFB gene, twice in a 
divergent orientation into pWIZ plasmid (Fig. 27A Probe 2). In this system, RNAi 
mediated gene silencing is activated by the expression of a hairpin of the 
sequence selected from the specific gene. This construct also contains an 
upstream activating sequence (UAS) that allows for controlling the expression of 
the hairpin RNA when combined with a GAL4 driver (Fig. 27B). To create the 
pWIZ-SAFB construct, I selected 731 bp of a non-conserved sequence specific 
to SAFB. I ensured the non-redundancy within the genome by using a tool in the 
Drosophila RNAi screening center that finds off-targets. Flies were transformed 
with the PWIZ-SAFB construct, and three independent insertion lines were used. 
These insertions did not cause obvious mutant phenotypes in the absence of 
GAL4 induction. 
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Fig. 27. Drosophila safb RNAi knockdown by double stranded RNA. A. 
Schematic representation of Drosophila safb gene, showing the probes used for 
its transcript knockdown in whole flies and S2 cells. B. Schematic representation 
of part of the pWIZ vector showing the cloned safb sequences.  
 
 
 
 I expressed the RNAi constructs, from the three different lines, using 
Act5C-Gal4 driver at three different temperatures, 18, 22 and 25oC. However, I 
did not observe abnormal phenotypes for the transgenic lines when crossed to 
this GAL4 driver. I tested the knockdown of safb mRNA by Reverse 
Transcription-PCR. I found safb mRNA still present in the flies (data not shown). 
To further analyze the Drosophila SAFB knock down, I crossed the same RNAi 
constructs to a GAL4 driver under the control of the eyeless promoter (ey-Gal4). 
Flies containing the transgene and GAL4 driver did not produce any obvious 
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phenotype in the eye compared with the ey-Gal4 parent. In conclusion, I did not 
observe a mutant phenotype using RNAi in the whole fly and in eye tissue. 
There are four possible explanations. First, since there was still enough amount 
of safb mRNA present in the whole flies after crossing to the Act5c- GAL4 driver, 
it is possible that this residual amount of mRNA is sufficient for normal function. 
Second, the lack of SAFB in flies does not cause a phenotype that is easily 
observed. Third, since the RNAi sequence used is directed against the RRM 
domain only present in the SAFB B splice form, the role of both forms may be 
redundant and the presence of the D form may overcome the lack of the B form. 
Lastly, even thought knockdown reduces Drosophila SAFB mRNA 
concentration, residual protein is stable and present in the cells even after RNAi. 
Unfortunately, there is not a SAFB antibody presently available to check protein 
perdurance in the transgenic flies.  
 Studies performed in cell culture have shown that knocking down human 
SAFB1 affects cell growth (114) and results in cell transformation (112). In the 
former case, knockdown of SAFB1 by siRNA shows increased cell growth. In the 
latter case, mouse embryonic fibroblast lacking the safb1 gene show increased 
features of transformed phenotypes such as loss of contact inhibition and an 
increase in anchorage-independent growth (112). To further describe the effects 
of SAFB removal, I knocked down SAFB mRNA levels using double stranded 
RNA-mediated interference (dsRNAi) in Drosophila S2 cells, a method shown to 
be effective in decreasing protein levels. I performed RNAi of Drosophila SAFB 
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by adding dsRNA directed against the sixth exon of the SAFB sequence. Six 
days later, the RNA levels were tested by Reverse Transcription followed by 
quantitative PCR (qPCR) and the cells were analyze by fluorescence 
microscopy. Drosophila SAFB dsRNA was prepared by bidirectional in vitro 
transcription from template DNA using T7 polymerase. This transcription 
resulted in a 731 bp long dsRNA covering part of the sixth exon of SAFB 
sequence that includes the RRM domain (Fig. 27 Probe2). As a control, cells 
were treated with dsRNA against LacZ and with no RNA at all. After incubating 
cells with a dsRNA against SAFB mRNA I was able to reduce the SAFB B form 
mRNA by at least  ~70% following RNAi treatment compared to the controls 
(Fig. 28). When analyzed using DAPI and antibodies against nuclear pore 
proteins, the RNAi treated cells did not exhibit any detectable nuclear 
morphological abnormalities compared to the control cells (dsLacz and No 
dsRNA). Furthermore, since human SAFB has been associated with apoptosis, 
and is cleavage by caspase-3, I examined the cells using Acridine Orange and 
antibodies against caspase-3, both of which are markers for apoptosis. No 
increase or decrease in apoptosis was detected in the knockdown cells 
compared to the wild type cells.  
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Fig. 28. Expression of Drosophila safb mRNAs determined by quantitative real 
time PCR. Cells were treated with dsRNA target the 6th exon of the safb gene, 
with dsLacz or with no dsRNA as control and the mRNA concentration was 
analyzed six days after treatment.  
 
 
 
 A key role of SAFB in apoptosis may explain the lack of SAFB1 in human 
culture, which causes cell immortalization (112). Therefore, I measured the 
growth rate of safb mRNA knockdown cell and the controls. The growth rate 
between knockdown cells and control cells are comparable (Fig 29), contrary to 
what has been seen previously where transient knockdown of human SAFB1 by 
RNAi showed increases in cell growth (114). Here, it is important to note that 
these results were obtained by transient transfection, so it is possible that a 
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stable transfection is necessary to see a phenotype. In addition, it will be 
interesting to test if knockdown of the safb has consequences in the expression 
of specific genes. 
 
 
 
 
Fig. 29. Growth curves of safb knockdown. Cells were transfected with dsRNA 
targeting the 6th exon of safb mRNAs. dsLacZ and no dsRNA were used as 
controls.   
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 One possible explanation for a lack of phenotype in knockdown cells is that 
the dsRNA used in the experiment was targeting the RRM domain, so it is 
possible that the SAFB D-form (lacking RRM domain) is still present and 
compensates for the lack of SAFB-B protein. To test this hypothesis, I performed 
RNAi by incubating cells with dsRNA that targets the SAP domain sequences 
and the eight-exon sequence. These new dsRNA were also prepared by in vitro 
transcription, which resulted in a 635 bp long dsRNA covering the SAP domain 
and a 648 bp dsRNA covering part of the eight exon of SAFB sequence. 
However treatment with these two new dsRNAs did not reduce SAFB mRNA 
effectively, compared to the dsRNA used previously (Fig. 30). Taken together, 
these data show that I was unable to knockdown safb efficiently, and despite 
lower levels of SAFB mRNA, it is still a possibility that the protein is present in 
knockdown cells. Unfortunately, there are no antibodies against Drosophila 
SAFB to address this questions, reason why we decided to make a safb 
knockout fly. 
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Fig. 30. Expression of Drosophila safb mRNAs determined by quantitative real 
time PCR. Cells were treated with dsRNA targeting the 6th and 8th exon and the 
SAP domain of the safb gene, with dsLacz or with no dsRNA as controls. The 
mRNA concentration was analyzed six days after treatment. 
 
 
 
 Lastly, the lack of phenotype of Drosophila SAFB knockdown may be a 
result of the cells used in this study. In humans, mutant safb phenotypes are 
seen in primary cultures from cells that are differentiated and mortal (112). S2 
cells are immortal, and their origin and type are not very clear. Therefore, the 
usage of other type of Drosophila cell lines for knockdown studies might provide 
a better model to discover a phenotype associated with the lack of SAFB. 
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Generation of Drosophila SAFB knockout by ends-out homologous 
recombination 
 
 Human SAFB1 and 2 have been associated with a variety of cellular 
processes, however the roles of these scaffold proteins in each of these 
processes is still under investigation. To understand the role that SAFB plays in 
nuclear organization, I needed cells with no SAFB function, therefore I created 
flies lacking the SAFB gene by homologous recombination (115). The 
homologous recombination donor construct was designed so that the flanking 
sequences of the Drosophila safb gene are flanking a white+ gene marker. In 
this way after recombination, the Drosophila safb is replaced with the white+ 
gene without affecting the genomic sequence of adjacent genes (Fig 31).  
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Fig. 31. Diagram representing ends-out targeting. Top shows a transgenic 
donor, which is the basis for targeting and contains I-SceI recognition sites and 
FRTs. FLP and induction in the fly are responsible for the generation of an extra 
chromosomal donor, leaving the remnant at the site of original integration. 
Homology between the extra chromosomal donor and the flanking regions of the 
target causes homologous recombination, replacing the Drosophila safb locus 
with white+. 
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 Briefly, female flies carrying the targeting construct  (P[w+safb- ]) were 
crossed to male flies carrying FLP recombinase and I-SceI genes regulated by 
heat-shock promoters (70I-SceI 70FLP/Sm1,CyO males) (Fig 32. G0). Larvae 
containing the targeting construct, FLP recombinase and I-SceI were heat 
shocked at 38° for 1 hr to induce FLP and I-SceI. All female progeny (red, white 
and mosaic eyes) were crossed to 70FLP/70FLP males (Fig. 32 G1). These 
crosses eliminate background in the next generation caused by females with the 
original targeting construct. Progeny with red eyes were then crossed to flies 
with white eyes (yw) to screen for potential homologous recombination events 
(Fig. 32 G2). For the ends out homologous recombination strategy, 1500 
crosses were screened. The progeny of these flies were selected for red eye 
color and the position of the donor construct on the third chromosome by meiotic 
mapping. Sixteen possible mobilizations were recovered and tested by PCR and 
restriction digestion to identify the safb knockout. 
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Fig. 32. Genetic crosses for targeting the safb gene. Flies carrying the donor 
construct were crossed to males containing FLP and I-SceI, and the progeny 
were heat shocked as larvae. Female progeny were crossed to males 
expressing FLP, and progeny with red eyes were collected and analyzed for 
proper targeting events. 
 
 
 
 Sixteen putative homologous recombination events were tested by PCR 
of genomic DNA, using specific primer combinations that align to the white+ gene 
and the outside sequences of the upstream and downstream flanking regions of 
the safb gene (Fig. 33 Arrowheads). There was PCR amplification of the 
upstream flanking region in just four of these events. In contrast, there was no 
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PCR product of the downstream region in any of the events tested. This may be 
a false negative since the band that is amplified is around 5Kb and a little more 
difficult to amplify. Homologous recombination was subsequently confirmed by 
restriction digestion and Southern blotting. Different restriction enzymes (Fig. 33) 
were used to test the replacement of safb by the white+ gene. Sequences of the 
flanking regions were used as probe in southern blots (Fig. 33 Yellow blocks). 
Therefore, whenever safb is present in its right location or homologous 
recombination occurs in which the white+ gene replace the safb gene, a specific 
pattern of digestion will result using the mentioned probes (Fig. 33A and B). 
However, if there is excision of the white+ gene and flanking regions from the 
donor but no recombination with the target, or if there is not excision of the donor 
at all, the pattern of digestion will be random and unpredicted, and will depend 
on the site of insertion. After restriction digest and Southern blot hybridization, 
only one of the initial sixteen mobilizations was determined to be due to 
homologous recombination (Fig. 33B). In this case the digestion pattern is what 
was predicted for a heterozygous line containing one chromosome with the safb 
gene and the other one containing the white+ gene (safb-) (Fig. 33). 
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Fig. 33. Analysis of safb knockout by restriction digest and Southern blot. A. 
Schematic of the safb genomic region containing the safb or the white+ gene. 
Restriction sequences and expected fragment sizes are shown for the restriction 
enzymes used in this study. B. Southern blot of genomic DNA from the safb 
knockout flies and from yw flies as a control. DNA was digested with various 
enzymes and the blot was hybridized using NotI-Acc65 and BsiWI-AscI probes.  
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Fig. 33. Continued. 
 
 
 
Drosophila SAFB is necessary for viability   
 
 During characterization of the Drosophila SAFB knockouts no homozygous 
flies were obtained. To confirm this, I crossed w1118;P[w+safb -]/TM3,Sb females 
and males and scored the progeny. No homozygous w1118;                      
P[w+safb –]/P[w+safb –] adult flies were obtained (Fig. 34). In order to determine 
the time of development in which the homozygous flies were dying I first 
examined if homozygous embryos can develop into larvae. Six hours after 
crossing heterozygous flies (w1118;P[w+ safb –]/TM3,Sb) in cages containing 
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apple juice agar plates, two hundred sixty embryos were taken and placed in 
new apple juice plates. In a cross with normal Mendelian segregation, we would 
expect half of the embryos to be heterozygous, P[w+ safb –]/TM3,Sb, a quarter of 
embryos to be homozygous for safb knockout, and a quarter to be lethal due to 
the balancers. Therefore, if safb is not necessary for viability, 75% of the 
population of embryos would hatch. However if safb knockout is necessary 
during embryogenesis as just 50% of the embryos hatch (Fig. 35).  
 
 
 
 
Fig.34. Genetic cross for safb- heterozygous showing all possible progeny.   
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 As result, out of 260 embryos I selected, 132 died in some point before 
hatching to larvae. Surviving larvae were transferred to vials and 98 of these 
developed to adults, representing P[w+safb-]/TM3,Sb phenotype (Fig. 35). The 
difference in the amount of adult flies compared to surviving larvae could be due 
to manipulation.  
 
 
 
 
Fig. 35. safb- homozygotes are embryonic lethal.  
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 To further characterized the causes of the lethality, I crossed females and 
males with safb- /TM6B,P {Dfd-EYFP} genotype, so that the heterozygous 
progeny would be fluorescent because of the EYFP marker while the 
homozygous safb-  would not. After observing the embryos under the 
microscope, no obvious morphological defects were observed. Additionally, after 
staining the embryos with DAPI, the size and shape of the nuclei looked normal 
and the cell cycle of the embryo at various stages looked as usual. Taken 
together these results demonstrate that SAFB is important for Drosophila 
viability, more specifically for embryonic development. However, the reason for 
the observed lethality is still unknown.  
 
Rescuing the Drosophila SAFB lethal phenotype 
 
 To confirm that the lethality seen in embryos is due to the lack of 
Drosophila SAFB and not another mutation, I used three different lines that 
contain the full genomic sequence of safb—two of them tagged with GFP in the 
N- or C-terminus—under UAS control. These transgenic lines were crossed to 
others harboring a GAL4 trans-activator gene under the control of Act5 promoter 
at three temperatures (18, 25 and 29oC) (Fig. 36). It was expected that in 
progeny that contained the UAS-SAFB-FL construct, Act5-GAL4, and were 
homozygous for safb-, the lethality would be rescued by expression of the 
transgenic SAFB. In contrast, I found that all the progeny obtained were safb- 
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heterozygous, no homozygous flies lacking SAFB were obtained, meaning that 
the expression of exogenous safb gene under UAS-GAL4 system could not 
rescue the knockout lethality (Fig. 36). 
 
 
 
 
 
Fig. 36. Crosses to rescue the safb- lethal phenotype. Genetic cross for safb- 
heterozygous showing all possible progeny. Females harboring a SAFB full-
length construct under UAS control were crossed to males carrying and actin-
GAL4 element.  
 
 
 
 One possibility for a lack of rescue of the lethality is that the transgene 
was not expressed. To test this hypothesis, I took advantage of the SAFB 
protein tagged with GFP. When females carrying a UAS-GFP-SAFB transgene 
are crossed to males harboring an Act5C-GAL4 element, the progeny would 
express the tagged protein. Therefore, I confirmed the presence of the SAFB by 
observing fluorescent adult fly tissue (Fig. 37).  
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Fig. 37. Comparison of GFP-SAFB expression in adult tissue. Comparison of 
GFP-SAFB expression between flies carrying both UAS-GFP-SAFB and the 
Act5C-GAL4—and flies harboring only the UAS-GFP-SAFB transgene. 
 
 
 
 There are other possible reasons why there was no rescue of the lethal 
phenotype using the safb transgene. First, the level of expression of the 
Drosophila SAFB may not be similar to the endogenous gene. Second, the safb 
transgene may not be expressed in the right tissue. To overcome these 
problems we are testing a new transgene that contains the full-length sequence 
of SAFB along with the upstream and downstream flanking sequences that may 
have necessary regulatory elements. An additional reason may be due to the 
presence of another mutation in the SAFB chromosome, which is also lethal.    
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Deficiency complementation 
 
 To further describe the null mutation produced by homologous 
recombination, I used deletions to determine if the lethality is due to SAFB 
knockout. Additionally, I tested two lethal P-element insertions from the 
Bloomington stock center collection, which map near the safb locus. Two of 
these P-elements are found between safb and the gene CG5808, which is 
transcribed from the opposite DNA strand (Fig. 38), and a lethal P-element 
insertion obtained from Dr Leonard Rabinow located in the 5’ end of the safb 
gene. 
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Fig. 38. Map showing the localization of the deficiencies that uncover safb 
(Df(3R)BSC520 and Df(3R)Exel6200) and P-elements that map next to the safb 
gene (20777 and17100).  
 
 
 
 I wanted to confirm that the lethal effect associated with safb- remained 
the same when hemyzygous with the P-element (safb-/ P-elements) or with the 
deficiencies (safb-/ Df). Two deficiencies used (Df(3R)BSC520 and 
Df(3R)Exel6200) have been determined to uncover the safb gene (CG6995) 
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region. Thus, when the SAFB knockout line was crossed to any of the 
deficiencies or P-elements, no trans-heterozygotes were expected (Fig. 39). 
 
 
 
 
 
Fig. 39. An example of a genetic cross to complement the lethal phenotype of 
safb-. In this case, females harboring the deficiency Df(3R)BSC520 are mated to 
safb- heterozygous males. Expected progeny are as follows: 25% trans-
heterozygous of safb-/Df, 50% of heterozygous (25% Df/TM3 and 25% safb-
/TM6C) and 25% TM6C/TM3,Sb. 
  
 
 
 When P[w+safb-] was crossed to the P-elements, 20777 and 17100, 
localized upstream of the safb gene (Fig. 37), I observed the percentage of 
trans-heterozygotes expected from a Mendelian segregation, suggesting that 
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either the P-elements or the safb knockout can complement the lethality of the 
other. In this case and base on the results of the safb knockout, I hypothesize 
that the P-elements are not impairing the expression of SAFB, rescuing the 
lethality cause by the lack of SAFB on the other chromosome. In contrast, the 
recovery of trans-heterozygotes when the knockout was crossed to the P-
element 20742, located at the 5’ of the gene, was near zero percent (Table 1). It 
is possible that the P-elements stock contains a loss-of-function allele, which 
can explain the lethality and the safb mRNA found in the trans-heterozygotes.  
 
 
 
Table 1. Crosses of the safb- to the different P-element insertions. The genotype 
of each P-element stock is described in the materials and methods. 
Heterozygous are written as: a.( P[w+safb-]/TM6B; P-element/TM3,Sb) b.        
(P-element/TM3,Sb; P[w+safb-]/TM3,Ser)   
Cross Heterozygous %  (n) Trans-heterozygous (n) 
safb- x 20777 64.5 (198) 35.5 (109) 
safb- x 17100 58.6 (110; 78)a 41.4 (133) 
safb- x 20742 99.2 (18;117)b 0.8 (1) 
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 Furthermore, the P[w+safb-] transgene was also crossed to deficiencies 
that presumably remove the safb gene. Deficiency 25023 does not uncover safb 
gene, so the cross of P[w+safb-] to 25023 was used as control, and as expected 
one third of the population was trans-heterozygous. However, when P[w+safb-] 
was crossed to 7679, a deficiency that removes safb, I observed the normal 
number of trans-heterozygotes, meaning normal viability for the               
P[w+safb-]/Df(3R)Exe16200. When I crossed P[w+safb-]  to 25024, I observed 
sub-viability of the trans-heterozygous, detecting just 6% of                     
P[w+safb-]/Df(3R)BSC520 (Table 2). Since there was a normal viability in the 
trans-heterozygous flies, I tested them for the presence of genomic safb by PCR 
using 2 different sets of primers. There was amplification of safb gene in the 
trans-heterozygous flies (data not shown).   
 
 
Table 2. Crosses of the safb- to the different deficiencies. The genotype of each 
deficiency stock is described in the materials and methods. a. Heterozygous are 
written as: ( P[w+SAFB-]/TM6B,Tb; Df 7679/TM3,Sb)  
Cross Heterozygous %  (n) Trans-heterozygous (n) 
safb- x Df(3R) Exe16200 71.3 (57, 35)a 28.7 (37) 
safb- x Df(3R)BSC520 93.7 (134) 6.3 (9) 
safb- x Df(3R)BSC519 70.2 (174) 29.8 (74) 
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 These results can only be obtained in two ways. First, the boundaries of 
the deletion are not well identified and the safb is in fact a remove, in this case 
we would expect rescue of the lethal phenotype and amplification of the safb 
gene and predicted restriction pattern in a southern (Fig. 40). Second, safb 
knockout, is not a knockout. In this case we would expect rescue of the lethal 
phenotype (maybe cause for some other mutation) and amplification of the safb 
gene, however, there would not be an easy explanation of the result I got testing 
the knockout by restriction digest and Southern blot (Fig 40). Therefore, it is 
important to characterize the safb knockout and the deficiencies used in this 
study.  
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Fig. 40. Schematic representation of results obtained from complementation 
experiments. The graph show homologous chromosomes of the progeny 
resulted from crossing the safb knockout with a deficiency.  
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CONCLUSIONS  
 
 Human SAFBs have been shown to be a multifunctional proteins that bind 
to DNA, RNA and other proteins, a reason why the genes have been associated 
with numerous processes such as gene expression, hormonal response, RNA 
splicing and apoptosis. Because human SAFB proteins are involved in such a 
diversity cellular processes, it is difficult to predict their physiological effects in 
vivo. Here, I describe the creation of a Drosophila safb knockout allele, which is 
the foundation for the study of the role of Drosophila SAFB in the nuclear matrix. 
Furthermore, this allele seems is homozygous embryonic lethal. However, I 
have not been able to rescue this phenotype, so more work is necessary in 
order to characterize this allele. Further studies showed that SAFB knockdown 
using dsRNA in S2 cells was not enough to deplete the safb mRNA completely 
and did not generate any obvious phenotype. Additionally, I generated and 
tested a fly stock containing a transgene that produces a hairpin-RNAi which 
should mediate knockdown of safb endogenous RNA via the RNAi pathway. 
Unfortunately this construct did not produce any obvious phenotype. Further 
studies will be essential to unravel the biological role SAFB. 
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MATERIALS AND METHODS 
 
Fly stock and genetics  
 
 Flies were maintained on standard cornmeal, yeast, and sugar medium 
with Tegosept. Crosses were performed at 25°. The wild-type was yellow1 
white67c23. The stocks used for ends out gene targeting of SAFB were: 
70FLP,70I-SceI: w1118; P{ry+, 70FLP}4, P{v+, 70I-SceI}2B, Sco/S2CyO; + and  
70FLP10: w1118; P{ry+, 70FLP}10/CyO; Sb/TM6,Ubx . 
The gal4 drivers used in these studies were: 1. Ey(8220): y[1] w[1118]; 
P{w[+mC]=ey3.5-GAL4.Exel}2  and  2.  Act (4414): y[1] w[*]; P{w[+mC]=Act5C-
GAL4}25FO1/CyO, y[+]. All fly lines are available from the Bloomington 
Drosophila Stock Center (http://flystocks.bio.indiana.edu). 
 
DNA constructs 
 
Drosophila safb was amplified from wild-type genomic DNA using 
Polymerase Chain Reaction and the PCR extended system of 5PRIME with 
Primer 1: 5’ CACCATGCCCGAGGCAGGAAAGAA 3’ and Primer 6: 5’ 
GTAGCGCGACACCGGTC 3’. The PCR products was cloned into the 
pENTR/D-TOPO Gateway entry vector according to the manufacturer's 
instructions (Invitrogen) and the complete sequence was verified by DNA 
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sequencing. safb sequence was then excised from pEntr/D-TOPO and ligated 
into, P-element plasmid pTW, pTGW and pTWG, from the Drosophila gateway 
collection, using the LR clonase reaction according to the manufacturer's 
instruction (Invitrogen). These constructs were injected into w1118 embryos by 
standard procedures (Genetic Services Inc.). 
 To create a SAFB RNAi construct, the sequence from the sixth exon was 
amplified by PCR using genomic DNA from a wild type fly as a template and the 
following forward 5’ ATATTCTAGATTGC CAACTCAAACAACAAGCAR 3’ and 
reverse primers 5’ATATTCTAGATTGC GCTCCTCACGTATCTTCT 3’. These 
primers contain XbaI sites in their tails. Fragments were sequentially cloned in 
opposite orientations into AvrII sites of the pWIZ vector. These constructs were 
injected into w1118 embryos by standard procedures (Genetic Services Inc.). 
 For ends-in gene targeting, the flanking sequences of the safb gene were 
amplified and cloned in the pW25.5 plasmid. To amplified the upstream flanking 
sequence primers 5’-CGCGGCGGCCGCTTGAAGTCGCACGCATTTTACA – 3’   
and 5’ GCGGGTACCTTTCGGGCATTTTACCTTGTTC 3’ were used. A NotI and 
Acc65I recognition sequences were added respectively at the 5’ of each primer. 
To amplify the downstream flanking sequence, primers 
5’CGCGTACGTTCCGCAGATTTCAGAGACGTA 3’   and 
5’CGGGCGCGCCTTACGTTCAACCGGCTATCAAG 3’ were used. A BsiWI and 
AscI recognition sequences were added respectively at the 5’ of each primer. 
Both fragments were cloned into pW25.5 plasmid that contains a white gene 
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flanked by Acc65I upstream and BsiWI downstream. This plasmid was injected 
into embryos to generate transgenic flies (Genetic Services Inc.). These 
transgenic flies were used to generate a null allele of safb by homologous 
recombination. (115) 
 
dsRNA interference knockdown in Drosophila S2 cells 
  
For dsRNA knockdowns, sequences from 3 different places of safb gene were 
amplified by PRC using three different set of primers containing the sequence 
for T7 promoter (TTATATCGACTCACTATGGGAGA) at the 5’: 1. FW 
5’GCCAACTCAAACAACAAGCA3’ and RV 5’GCGCTCCTCACGTATCTTCT3’  
2. FW 5’GCGCAGCACCTATGACAAAAA3’ RV 
5’GAGCAGACTTTTGCCACGAAT3’ 
3. FW 5’AACGCGAGTTGGAGAC3’ and  
RV 5’CTCCGTCGTCATTCTTC3’. LacZ gene was used as control and was 
amplified using primers:  FW 
5’TAATACGACTCACTATAGGAGGTATTCGCTG3’ and RV 
5’TAATACGACTCACTATAGGCGATCGTAATCACC3’. Forward and reverse 
strands were transcribed by T7 polymerase in vitro using MEGAscript T7 Kit 
(Ambion, Inc). After phenol extraction, precipitation, and quantification of yields, 
the strands were annealed. Drosophila S2 cells were grown in Schneider's 
medium (Invitrogen) supplemented with Heat inactivated Fetal Bovian Serum 
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(FBS) (GIBCO) and penicillin/streptomycin. S2 cells were harvest, rinse and 
diluted in serum-free medium to a density of 0.5- 1.0 x 106 cell/mL. One milliliter 
of cells was seeded per well using a 6-well culture dish (Corning). dsRNA was 
added directly to the media to a final concentration of 19 µg. The cells were 
incubated for 1 hour at room temperature followed by addition of 2 ml of 1× 
Schneider's media containing FBS. The cells were incubated for an additional 3 
to 6 days to allow for turnover of the target protein. 
 
Reverse transcription- Quantitative Real Time PCR (qPCR)  
 Total RNA from S2 cells was isolated by lysis in TRIzol (Invitrogen), 
followed by chloroform/isopropanol extraction, ethanol precipitation, and 
resuspension in DEPC-water.  The RNA preparation was then used for reverse 
transcription using the following primer: SAFB: 
5’GTCGTTACGCTTGCTGGAGT3’ and control tRNA: 
5’TGGAGATGCGGGGTATCGATC3’. Reverse Transcription was performed 
using M-MuLV Reverse Transcriptase (NewEngland BioLabs inc.) and 500ng of 
total RNA according to the manufacture’s protocol.  
cDNA samples were analyzed by quantitative real-time PCR (qPCR). Primers to 
amplify a fragment of the safb cDNA ( 5’ATCCTCGTCGAGCACCAA3’ and  
5’GTCGTTACGCTTGCTGGAGT3’) and a sequence of the tRNA 
(5’GTAGCTCAGATGGTAGAGCGCT3’ and 
5’TGGAGATGCGGGGTATCGATC3’) were used. After confirming single melting 
 113 
curve kinetics for the primers, triplicate reaction containing 1uL of reverse 
transcriptase reaction of SAFB and 0.07uL of tRNA were amplified using the 
Power SYBR Green master mix (Applied Biosystems) reagent, 500 nm primers, 
ABI Step-One real-time polymerase chain reaction machine (Applied 
Biosystems) running Step-One v1.0 software. The qPCR parameters were: 40 
cycles alternating between 95° for 3 sec and 60° for 30. 
 Amplification data were processed by determining the point at which 
fluorescence first crossed a threshold of 10 standard deviations above the 
average of all previous cycles (“no amplification”) of fluorescence from each 
extract, as determined by the Step-One software. Samples in discordance with 
the other samples were interpreted as errors in reaction or reaction preparation 
and were excluded. Cycle differences between SAFB and tRNA expression of 
the same treatment (“ΔCT”) were compared to the same measurement from cell 
that did not were treated with any ds RNA sequences (“ΔΔCT”) generating the 
percentage of SAFB RNA quantity.  
 
Southern blots 
 
 DNA from adult flies was prepared using a modified procedure from K. 
Dobie (116). The nucleic acid was cut with XhoI, ScaI, BglII, SacI, Acc65I, 
EcoRV, SmaI and XbaI according to the manufacturer’s specifications (New 
England Biolabs). DNA was separated by electrophoresis on 1% agarose gel 
and transferred overnight onto nylon membrane by capillary blotting in 1x ABB 
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(1.5M NaCl, 400 mN NaOH).  Radioactive probes, corresponding to each 
flanking region of safb gene, were hybridizing over night in QuickHyb 
hybridization solution (Stratagene). All blots were washed two times at 65°C for 
15 min each in C&G1 buffer (40mM Sodium phosphate pH7.2, 5% SDS, 1mM 
EDTA, 0.5% BSA), followed by two times at 65°C for 15 min each in C&G2 
buffer (40mM Sodium phosphate pH7.2, 1% SDS, 1mM EDTA). 
 
Viability assays 
 
 Heterozygous SAFB knock out flies (w[1118]; SAFB Pw+ CA29.1/ TM3,Sb) 
were put in a fly cage sealed with a grape juice agar plates smeared with yeast 
paste. After 6 hours embryos were taken from the agar plates and were aligned 
on a new apple juice plates without yeast paste. Hatched larvae were counted 
and transferred to vials, and pupae and adults were counted as they appeared.  
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CHAPTER V 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
 The topic of my research is to determine the role of the nuclear matrix in 
gene expression. I have focused on the characterization of a protein associated 
with chromatin organization, gene expression, RNA splicing and the hormonal 
response: the Drosophila homologue of the human nuclear matrix protein 
Scaffold Attachment Factor B (SAFB). With this, I hoped to validate the use of 
Drosophila as a model in which to study SAFB, and expand our knowledge of 
the protein and the nuclear matrix using a simpler organism.  
 In this study, I have demonstrated that the Drosophila CG6995 gene is 
the homologue of human Scaffold Attachment Factor B (SAFB), based on 
sequence similarities, protein domain identity, mRNA expression patterns and 
protein localization in the nucleus. In addition to what is known from cell culture 
studies in mammalian cells, I discovered a new SAFB splice-form, which lacks 
the RRM domain. I have also described the exclusion of SAFB RNA from 
germline stem cells. Additionally, I described the distribution of Drosophila SAFB 
on DNA, and its redistribution to heat shock loci after heat shock induction. I also 
created a fly lacking safb that will be used to further characterize of Drosophila 
SAFB.  
 Since it was first observed in 1974 (16), the nuclear matrix has been 
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described as a cytoskeletal structure inside the nucleus composed of non-
histone proteins and nucleic acids. Nevertheless, until recently there has been 
significant discussion as to whether the nuclear matrix is a real entity or just an 
artifact caused by the severe treatments applied to the nucleus. Yet, the 
development of techniques, which allow for nuclear matrix visualization under 
better physiological conditions, is leading to its general acceptance (23, 117-
119). These studies have shown that the nuclear matrix is a platform in which 
cellular processes such as chromatin organization, DNA repair, gene 
expression, DNA replication and RNA splicing occur. Furthermore, the 
distribution and expression of nuclear matrix proteins are associated with 
numerous cancers and other pathologies (81, 82).  
 However, the majority of knowledge regarding the nuclear matrix comes 
from biochemical studies from cell growing in the artificial environments of cell 
cultures. Because of this, it was important to find a model organism that allows 
us to study the role of nuclear matrix proteins in the context of a whole organism. 
In this way, the fruit fly Drosophila melanogaster offers the simplicity that permits 
the analysis of nuclear matrix proteins due to its easy manipulations and the 
variety of cytological, genetic and molecular tools available. In addition, some 
studies characterizing the S/MAR sequences of different genes (53, 54, 120, 
121), the nuclear matrix (122) and some of the nuclear matrix protein (55, 123-
125) in Drosophila provide a good foundation for my studies. I hoped to use 
Drosophila to further understand the role of nuclear matrix in gene expression. 
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Ultimately, this will help elucidate potential mechanisms of gene regulation 
dependent on nuclear matrix and chromatin organization.   
 One of the most abundant proteins found in human nuclear matrix 
extracts is Scaffold Attachment Factor B (SAFB). Human SAFB was first 
characterized as an S/MAR DNA attachment protein related to chromatin loop 
formation and organization. Interestingly, numerous studies have also 
associated human SAFB with gene expression (84), RNA splicing (86, 91) and 
hormonal responses (80, 90), processes also linked to nuclear matrix functions. 
These results highlight the importance of studying SAFB in Drosophila. A better 
understanding of this protein will help us in elucidating the role of the nuclear 
matrix in the cell, specifically, its role in gene expression and chromatin 
organization. 
 Here, I show that just as its human homologue, the Drosophila CG6995 
gene sequence is a predicted protein that contains a DNA binding domain in its 
N terminus called SAP domain, an RNA binding motif called RRM, and Gly-, 
Glu- and Arg- rich domains. It has been shown that the different domains of 
human SAFB have specific function in the protein. In that way, the SAP domain 
binds S/MARs specifically (85, 88) and is cleaved during apoptosis by caspase 3 
(111), and that the G and R/E rich regions mediates protein-protein interactions 
(111). My results show that in Drosophila, the SAP domain is important for the 
localization of SAFB to certain specific DNA locations (as seen in its localization 
in polytene chromosomes). However, it is still unclear whether DNA or RNA 
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binding activity or protein-protein interaction is necessary for association with the 
nuclear matrix. It would be interesting to identify the cause that mediates this 
association. 
  In addition to the already described Drosophila SAFB, I have identified a 
novel SAFB splice form that lacks the RNA binding domain. This new splice form 
may be significant in understanding the importance of the proteins RNA binding 
activity in chromatin organization and gene expression. However, the cellular 
localization and the function of the SAFB RRM-less isoform is still unknown.  
 The expression pattern of human safb (87) is similar to Drosophila safb 
gene, where the gene product is ubiquitously expressed but enriched in specific 
tissues—such as the central nervous system. Additionally, I showed that 
Drosophila safb is expressed in specialized cells in testis and ovaries but is not 
detectable in the germline stem cells.   
 My experiments describing the localization of a tagged version of 
Drosophila SAFB show that the protein is localized in the nucleus in three 
different compartments, similar to human SAFB1 and 2 localization. SAFB is 
found in the nuclear matrix, throughout the nucleoplasm where it forms speckles. 
It is known that human SAFB2 co-localizes with Sam68, an RNA binding protein, 
in the speckles in what seems to be splicing complexes. In Drosophila, I showed 
that SAFB speckles have a different nuclear distribution from the elongating 
RNA polymerase II (RNAPII) and from CTCF, a protein involved in insulator 
activity. Indeed, I describe the localization of Drosophila SAFB in the DNA, by 
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taking advantage of the large polytene chromosomes. Contrary to what I 
expected from SAFB binding S/MAR sequences, Drosophila SAFB localizes to 
many specific loci on the chromosomes, with more affinity in some bands than in 
others. Additionally, SAFB co-localizes with elongating RNAPII in some of the 
loci, but not in others. This banding pattern is mostly RNA dependent localization 
possibly by the RRM domain, as seen in loss of localization after treating nuclei 
with RNAse. To a lesser degree the banding localization is DNA binding 
dependent, seen after RNAse treatment of nuclei expressing the SAP-less 
truncated version of the protein. In order to find the role of SAFB in gene 
expression, this observation needs to be further evaluated by finding the specific 
sequences to which SAFB directly binds (Fig. 41). 
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Fig. 41. A Schematic diagram representing the different roles of Drosophila 
SAFB presented in this work.   
 
 
 
 My results raise questions about how the nuclear matrix functions. More 
experiments are necessary to identify the concentration and characteristics of 
the SAFB protein associated with the nuclear matrix versus the protein localized 
in the nucleoplasm, since these population may potentially differ in function. For 
instance, SAFB is found in speckles, probably overlapping with splicing proteins, 
in agreement with SAFB association with RNA. However, it is still not clear what 
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populations of the protein—those associated with the nuclear matrix or those 
found in the nucleoplams—play that role in the cell. Knowing these roles of each 
protein population will help us to understand more clearly the role of the nuclear 
matrix in different cellular processes, including gene expression.  
 A possible explanation for different Drosophila SAFB localization can be 
post-translational modifications. Further computer analysis of the predicted 
protein sequences indicate the presence of many potential phosphorylation 
sites, eleven of which are found in vivo. Three of these sites may be associated 
with known DoA and CK2 Kinases. Thus, it will be valuable to know the 
modification status of the proteins associated to the nuclear matrix and the 
proteins found throughout the nucleus.  
 To better understand the role of SAFB in the cells, I knocked down safb 
expression via RNAi in whole flies and in S2 cells. Although it has been shown 
that knockdown of SAFB in certain human cells results in an increase in cells 
growth, I did not observed this or any other obvious phenotype. This can be 
explained by the differences in cell types, but it is also possible that the level of 
there was knockdown of RNA, while the protein remains present. Certainly, 
these knockdown experiments can be used once more information is known 
about SAFB.  
 Finally, I created a safb knockout by using ends-out gene targeting by 
homologous recombination. The only positive targeting event was verified by 
restriction digestion with eight different enzymes by Southern blotting. The safb 
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knockout appears to cause embryonic lethality. However, complementation 
studies that I performed did not produce conclusive results. First, a tagged and 
untagged version of SAFB expressed using an upstream UAS sequences and 
GAL4 under Act5C promoter did not rescue the lethal phenotype. It is possible 
that the protein is not expressed in the right tissues or in the correct 
concentration. However I constructed a fly stock that contains the entire safb 
gene plus the upstream and downstream sequence, and crosses have been 
made to test for its ability to rescue the lethal phenotype. Second, crosses made 
between the safb knockout and different deletions that remove the safb gene, 
did no show any lethal phenotype. Thus, further studies are necessary to either 
show that the lethal phenotype observed is due to the lack of SAFB and not to 
some other mutations. 
 In summary, my studies validate the use of Drosophila for the study of 
Scaffold Attachment Factor B. They also provide the bases for the study of 
SAFB, which may potentially give insight into the different roles of nuclear matrix 
in the cell. I have generated tools that will be key in answering the question my 
thesis work has generated. 
 
 
 
 
 
 123 
REFERENCES 
 
 
1. Kalverda B, Roling MD, & Fornerod M (2008) Chromatin organization in 
relation to the nuclear periphery. FEBS Lett 582(14):2017-2022. 
2. Lodish HF (2000) in Molecular Cell Biology, 4th ed, eds Tontomoz M, 
Pantages E, RIce E (W. H. Freeman, New York), pp 1017-1036. 
3. Bednar J, Horowitz RA, Grigoryev SA, Carruthers LM, Hansen JC, Koster 
AJ, & Woodcock CL (1998) Nucleosomes, linker DNA, and linker histone 
form a unique structural motif that directs the higher-order folding and 
compaction of chromatin. Proc Natl Acad Sci USA 95(24):14173-14178. 
4. Gilbert N, Gilchrist S, & Bickmore WA (2005) Chromatin organization in 
the mammalian nucleus. Int Rev Cytol 242:283-336. 
5. Tremethick DJ (2007) Higher-order structures of chromatin: the elusive 30 
nm fiber. Cell 128(4):651-654. 
6. Heng HH, Krawetz SA, Lu W, Bremer S, Liu G, & Ye CJ (2001) Re-
defining the chromatin loop domain. Cytogenet Cell Genet 93(3-4):155-
161. 
7. Adolphs KW, Cheng SM, Paulson JR, & Laemmli UK (1977) Isolation of a 
protein scaffold from mitotic HeLa cell chromosomes. Proc Natl Acad Sci 
USA 74(11):4937-4941. 
8. Paulson JR & Laemmli UK (1977) The structure of histone-depleted 
metaphase chromosomes. Cell 12(3):817-828. 
9. Nelson WG, Pienta KJ, Barrack ER, & Coffey DS (1986) The role of the 
nuclear matrix in the organization and function of DNA. Annu Rev 
Biophys Biophys Chem 15:457-475. 
 124 
10. Saitoh Y & Laemmli UK (1994) Metaphase chromosome structure: bands 
arise from a differential folding path of the highly AT-rich scaffold. Cell 
76(4):609-622. 
11. Kas E, Izaurralde E, & Laemmli UK (1989) Specific inhibition of DNA 
binding to nuclear scaffolds and histone H1 by distamycin. The role of 
oligo(dA).oligo(dT) tracts. J Mol Biol 210(3):587-599. 
12. Gluch A, Vidakovic M, & Bode J (2008) Scaffold/matrix attachment 
regions (S/MARs): relevance for disease and therapy. Handb Exp 
Pharmacol (186):67-103. 
13. Mirkovitch J, Mirault ME, & Laemmli UK (1984) Organization of the 
higher-order chromatin loop: specific DNA attachment sites on nuclear 
scaffold. Cell 39(1):223-232. 
14. Hizume K, Araki S, Yoshikawa K, & Takeyasu K (2007) Topoisomerase II, 
scaffold component, promotes chromatin compaction in vitro in a linker-
histone H1-dependent manner. Nucleic Acids Res 35(8):2787-2799. 
15. Berezney R (1995) in Nuclear Matrix: Structural and Functional 
Organization, eds Academic press (San Diego, California) pp. 
16. Berezney R & Coffey DS (1977) Nuclear matrix. Isolation and 
characterization of a framework structure from rat liver nuclei. J Cell Biol 
73(3):616-637. 
17. Davie JR (1997) Nuclear matrix, dynamic histone acetylation and 
transcriptionally active chromatin. Mol Biol Rep 24(3):197-207. 
18. Pederson T (1998) Thinking about a nuclear matrix. J Mol Biol 
277(2):147-159. 
19. Vogelstein B, Pardoll DM, & Coffey DS (1980) Supercoiled loops and 
eucaryotic DNA replicaton. Cell 22(1 Pt 1):79-85. 
 125 
20. Driel RV (1997) Nuclear Organization, Chromatin Structure, and Gene 
Expression (Oxford University Press, New York). 
21. Fiorini A, Gouveia Fde S, & Fernandez MA (2006) Scaffold/matrix 
attachment regions and intrinsic DNA curvature. Biochemistry (Mosc) 
71(5):481-488. 
22. Paul AL & Ferl RJ (1999) Higher-order chromatin structure: Looping long 
molecules. Plant Mol Biol 41(6):713-720. 
23. Mika S & Rost B (2005) NMPdb: Database of nuclear matrix proteins. 
Nucleic Acids Res 33(Database issue):D160-163. 
24. Elcock LS & Bridger JM (2008) Exploring the effects of a dysfunctional 
nuclear matrix. Biochem Soc Trans 36(Pt 6):1378-1383. 
25. Allen SL, Berezney R, & Coffey DS (1977) Phosphorylation of nuclear 
matrix proteins in isolated regenerating rat liver nuclei. Biochem Biophys 
Res Commun 75(1):111-116. 
26. Henry SM & Hodge LD (1983) Nuclear matrix: A cell-cycle-dependent site 
of increased intranuclear protein phosphorylation. Eur J Biochem 
133(1):23-29. 
27. Mittnacht S, Lees JA, Desai D, Harlow E, Morgan DO, & Weinberg RA 
(1994) Distinct sub-populations of the retinoblastoma protein show a 
distinct pattern of phosphorylation. EMBO J 13(1):118-127. 
28. Vincent M, Lauriault P, Dubois MF, Lavoie S, Bensaude O, & Chabot B 
(1996) The nuclear matrix protein p255 is a highly phosphorylated form of 
RNA polymerase II largest subunit which associates with spliceosomes. 
Nucleic Acids Res 24(23):4649-4652. 
29. Radha V, Nambirajan S, & Swarup G (1996) Association of Lyn tyrosine 
kinase with the nuclear matrix and cell-cycle-dependent changes in 
matrix-associated tyrosine kinase activity. Eur J Biochem 236(2):352-359. 
 126 
30. Liu J, Bramblett D, Zhu Q, Lozano M, Kobayashi R, Ross SR, & Dudley 
JP (1997) The matrix attachment region-binding protein SATB1 
participates in negative regulation of tissue-specific gene expression. Mol 
Cell Biol 17(9):5275-5287. 
31. Albrethsen J, Knol JC, & Jimenez CR (2009) Unravelling the nuclear 
matrix proteome. J Proteomics 72(1):71-81. 
32. Jiang M, Axe T, Holgate R, Rubbi CP, Okorokov AL, Mee T, & Milner J 
(2001) p53 binds the nuclear matrix in normal cells: Binding involves the 
proline-rich domain of p53 and increases following genotoxic stress. 
Oncogene 20(39):5449-5458. 
33. Sadoni N, Cardoso MC, Stelzer EH, Leonhardt H, & Zink D (2004) Stable 
chromosomal units determine the spatial and temporal organization of 
DNA replication. J Cell Sci 117(Pt 22):5353-5365. 
34. Cseresnyes Z, Schwarz U, & Green CM (2009) Analysis of replication 
factories in human cells by super-resolution light microscopy. BMC Cell 
Biol 10:88-100. 
35. Ottaviani D, Lever E, Takousis P, & Sheer D (2008) Anchoring the 
genome. Genome Biol 9(1):201-207. 
36. Jenke AC, Stehle IM, Herrmann F, Eisenberger T, Baiker A, Bode J, 
Fackelmayer FO, & Lipps HJ (2004) Nuclear scaffold/matrix attached 
region modules linked to a transcription unit are sufficient for replication 
and maintenance of a mammalian episome. Proc Natl Acad Sci USA 
101(31):11322-11327. 
37. Nakayasu H & Berezney R (1989) Mapping replicational sites in the 
eucaryotic cell nucleus. J Cell Biol 108(1):1-11. 
38. Radichev I, Parashkevova A, & Anachkova B (2005) Initiation of DNA 
replication at a nuclear matrix-attached chromatin fraction. J Cell Physiol 
203(1):71-77. 
 127 
39. Djeliova V, Russev G, & Anachkova B (2001) Dynamics of association of 
origins of DNA replication with the nuclear matrix during the cell cycle. 
Nucleic Acids Res 29(15):3181-3187. 
40. Anachkova B, Djeliova V, & Russev G (2005) Nuclear matrix support of 
DNA replication. J Cell Biochem 96(5):951-961. 
41. Cook PR (1999) The organization of replication and transcription. Science 
284(5421):1790-1795. 
42. Lagarkova MA, Svetlova E, Giacca M, Falaschi A, & Razin SV (1998) 
DNA loop anchorage region colocalizes with the replication origin located 
downstream to the human gene encoding lamin B2. J Cell Biochem 
69(1):13-18. 
43. Pardoll DM, Vogelstein B, & Coffey DS (1980) A fixed site of DNA 
replication in eucaryotic cells. Cell 19(2):527-536. 
44. Wansink DG, Schul W, van der Kraan I, van Steensel B, van Driel R, & de 
Jong L (1993) Fluorescent labeling of nascent RNA reveals transcription 
by RNA polymerase II in domains scattered throughout the nucleus. J 
Cell Biol 122(2):283-293. 
45. Taddei A (2007) Active genes at the nuclear pore complex. Curr Opin Cell 
Biol 19(3):305-310. 
46. Trendelenburg MF (1983) Progress in visualization of eukaryotic gene 
transcription. Hum Genet 63(3):197-215. 
47. Jackson DA (1997) Chromatin domains and nuclear compartments: 
Establishing sites of gene expression in eukaryotic nuclei. Mol Biol Rep 
24(3):209-220. 
48. Stein GS, Montecino M, van Wijnen AJ, Stein JL, & Lian JB (2000) 
Nuclear structure-gene expression interrelationships: Implications for 
aberrant gene expression in cancer. Cancer Res 60(8):2067-2076. 
 128 
49. Jackson DA & Cook PR (1985) Transcription occurs at a nucleoskeleton. 
EMBO J 4(4):919-925. 
50. Gasser SM & Laemmli UK (1986) Cohabitation of scaffold binding regions 
with upstream/enhancer elements of three developmentally regulated 
genes of D. melanogaster. Cell 46(4):521-530. 
51. Linnemann AK, Platts AE, & Krawetz SA (2009) Differential nuclear 
scaffold/matrix attachment marks expressed genes. Hum Mol Genet 
18(4):645-654. 
52. Galande S, Purbey PK, Notani D, & Kumar PP (2007) The third 
dimension of gene regulation: Organization of dynamic chromatin 
loopscape by SATB1. Curr Opin Genet Dev 17(5):408-414. 
53. Hiromi Y, Kuroiwa A, & Gehring WJ (1985) Control elements of the 
Drosophila segmentation gene fushi tarazu. Cell 43(3 Pt 2):603-613. 
54. Nabirochkin S, Ossokina M, & Heidmann T (1998) A nuclear 
matrix/scaffold attachment region co-localizes with the gypsy 
retrotransposon insulator sequence. J Biol Chem 273(4):2473-2479. 
55. Pathak RU, Rangaraj N, Kallappagoudar S, Mishra K, & Mishra RK 
(2007) Boundary element-associated factor 32B connects chromatin 
domains to the nuclear matrix. Mol Cell Biol 27(13):4796-4806. 
56. Yasui D, Miyano M, Cai S, Varga-Weisz P, & Kohwi-Shigematsu T (2002) 
SATB1 targets chromatin remodelling to regulate genes over long 
distances. Nature 419(6907):641-645. 
57. Martens JH, Verlaan M, Kalkhoven E, Dorsman JC, & Zantema A (2002) 
Scaffold/matrix attachment region elements interact with a p300-scaffold 
attachment factor A complex and are bound by acetylated nucleosomes. 
Mol Cell Biol 22(8):2598-2606. 
 129 
58. Kukalev A, Nord Y, Palmberg C, Bergman T, & Percipalle P (2005) Actin 
and hnRNP U cooperate for productive transcription by RNA polymerase 
II. Nat Struct Mol Biol 12(3):238-244. 
59. Ahmed S & Brickner JH (2007) Regulation and epigenetic control of 
transcription at the nuclear periphery. Trends Genet 23(8):396-402. 
60. Towbin BD, Meister P, & Gasser SM (2009) The nuclear envelope: A 
scaffold for silencing? Curr Opin Genet Dev 19(2):180-186. 
61. Lauber AH, Barrett TJ, Subramaniam M, Schuchard M, & Spelsberg TC 
(1997) A DNA-binding element for a steroid receptor-binding factor is 
flanked by dual nuclear matrix DNA attachment sites in the c-myc gene 
promoter. J Biol Chem 272(39):24657-24665. 
62. Ciejek EM, Nordstrom JL, Tsai MJ, & O'Malley BW (1982) Ribonucleic 
acid precursors are associated with the chick oviduct nuclear matrix. 
Biochemistry 21(20):4945-4953. 
63. Wang J, Cao LG, Wang YL, & Pederson T (1991) Localization of pre-
messenger RNA at discrete nuclear sites. Proc Natl Acad Sci USA 
88(16):7391-7395. 
64. Dundr M & Misteli T (2001) Functional architecture in the cell nucleus. 
Biochem J 356(Pt 2):297-310. 
65. Vogelstein B & Hunt BF (1982) A subset of small nuclear 
ribonucleoprotein particle antigens is a component of the nuclear matrix. 
Biochem Biophys Res Commun 105(3):1224-1232. 
66. Meissner M, Dechat T, Gerner C, Grimm R, Foisner R, & Sauermann G 
(2000) Differential nuclear localization and nuclear matrix association of 
the splicing factors PSF and PTB. J Cell Biochem 76(4):559-566. 
67. Sergeant KA, Bourgeois CF, Dalgliesh C, Venables JP, Stevenin J, & 
Elliott DJ (2007) Alternative RNA splicing complexes containing the 
scaffold attachment factor SAFB2. J Cell Sci 120(Pt 2):309-319. 
 130 
68. Blencowe BJ, Nickerson JA, Issner R, Penman S, & Sharp PA (1994) 
Association of nuclear matrix antigens with exon-containing splicing 
complexes. J Cell Biol 127(3):593-607. 
69. Smith HC, Harris SG, Zillmann M, & Berget SM (1989) Evidence that a 
nuclear matrix protein participates in premessenger RNA splicing. Exp 
Cell Res 182(2):521-533. 
70. Zeitlin S, Parent A, Silverstein S, & Efstratiadis A (1987) Pre-mRNA 
splicing and the nuclear matrix. Mol Cell Biol 7(1):111-120. 
71. Mariman EC, van Eekelen CA, Reinders RJ, Berns AJ, & van Venrooij 
WJ (1982) Adenoviral heterogeneous nuclear RNA is associated with the 
host nuclear matrix during splicing. J Mol Biol 154(1):103-119. 
72. Xing YG & Lawrence JB (1991) Preservation of specific RNA distribution 
within the chromatin-depleted nuclear substructure demonstrated by in 
situ hybridization coupled with biochemical fractionation. J Cell Biol 
112(6):1055-1063. 
73. Nickerson JA, Krochmalnic G, Wan KM, & Penman S (1989) Chromatin 
architecture and nuclear RNA. Proc Natl Acad Sci USA 86(1):177-181. 
74. Tang Y & DeFranco DB (1996) ATP-dependent release of glucocorticoid 
receptors from the nuclear matrix. Mol Cell Biol 16(5):1989-2001. 
75. Metzger DA & Korach KS (1990) Cell-free interaction of the estrogen 
receptor with mouse uterine nuclear matrix: Evidence of saturability, 
specificity, and resistance to KCl extraction. Endocrinology 126(4):2190-
2195. 
76. Barrack ER (1983) The nuclear matrix of the prostate contains acceptor 
sites for androgen receptors. Endocrinology 113(1):430-432. 
77. Barrack ER & Coffey DS (1980) The specific binding of estrogens and 
androgens to the nuclear matrix of sex hormone responsive tissues. J 
Biol Chem 255(15):7265-7275. 
 131 
78. van Steensel B, Jenster G, Damm K, Brinkmann AO, & van Driel R 
(1995) Domains of the human androgen receptor and glucocorticoid 
receptor involved in binding to the nuclear matrix. J Cell Biochem 
57(3):465-478. 
79. DeFranco DB & Guerrero J (2000) Nuclear matrix targeting of steroid 
receptors: Specific signal sequences and acceptor proteins. Crit Rev 
Eukaryot Gene Expr 10(1):39-44. 
80. Oesterreich S, Zhang Q, Hopp T, Fuqua SA, Michaelis M, Zhao HH, 
Davie JR, Osborne CK, & Lee AV (2000) Tamoxifen-bound estrogen 
receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-
B, a novel inhibitor of ER-mediated transactivation. Mol Endocrinol 
14(3):369-381. 
81. Sjakste N & Sjakste T (2005) Nuclear matrix proteins and hereditary 
diseases. Genetika 41(3):293-298. 
82. Sjakste N, Sjakste T, & Vikmanis U (2004) Role of the nuclear matrix 
proteins in malignant transformation and cancer diagnosis. Exp Oncol 
26(3):170-178. 
83. Barboro P, Rubagotti A, Boccardo F, Carnemolla B, Darrigo C, Patrone E, 
& Balbi C (2005) Nuclear matrix protein expression in prostate cancer: 
Possible prognostic and diagnostic applications. Anticancer Res 
25(6B):3999-4004. 
84. Oesterreich S, Lee AV, Sullivan TM, Samuel SK, Davie JR, & Fuqua SA 
(1997) Novel nuclear matrix protein HET binds to and influences activity 
of the HSP27 promoter in human breast cancer cells. J Cell Biochem 
67(2):275-286. 
85. Renz A & Fackelmayer FO (1996) Purification and molecular cloning of 
the scaffold attachment factor B (SAF-B), a novel human nuclear protein 
that specifically binds to S/MAR-DNA. Nucleic Acids Res 24(5):843-849. 
86. Weighardt F, Cobianchi F, Cartegni L, Chiodi I, Villa A, Riva S, & 
Biamonti G (1999) A novel hnRNP protein (HAP/SAF-B) enters a subset 
 132 
of hnRNP complexes and relocates in nuclear granules in response to 
heat shock. J Cell Sci 112 ( Pt 10):1465-1476. 
87. Townson SM, Dobrzycka KM, Lee AV, Air M, Deng W, Kang K, Jiang S, 
Kioka N, Michaelis K, & Oesterreich S (2003) SAFB2, a new scaffold 
attachment factor homolog and estrogen receptor corepressor. J Biol 
Chem 278(22):20059-20068. 
88. Aravind L & Koonin EV (2000) SAP: A putative DNA-binding motif 
involved in chromosomal organization. Trends Biochem Sci 25(3):112-
114. 
89. Tsianou D, Nikolakaki E, Tzitzira A, Bonanou S, Giannakouros T, & 
Georgatsou E (2009) The enzymatic activity of SR protein kinases 1 and 
1a is negatively affected by interaction with scaffold attachment factors 
B1 and 2. FEBS J 276(18):5212-5227. 
90. Townson SM, Kang K, Lee AV, & Oesterreich S (2004) Structure-function 
analysis of the estrogen receptor alpha corepressor scaffold attachment 
factor-B1: Identification of a potent transcriptional repression domain. J 
Biol Chem 279(25):26074-26081. 
91. Nayler O, Stratling W, Bourquin JP, Stagljar I, Lindemann L, Jasper H, 
Hartmann AM, Fackelmayer FO, Ullrich A, & Stamm S (1998) SAF-B 
protein couples transcription and pre-mRNA splicing to SAR/MAR 
elements. Nucleic Acids Res 26(15):3542-3549. 
92. Blom N, Gammeltoft S, & Brunak S (1999) Sequence and structure-based 
prediction of eukaryotic protein phosphorylation sites. J Mol Biol 
294(5):1351-1362. 
93. Huang HD, Lee TY, Tzeng SW, & Horng JT (2005) KinasePhos: A web 
tool for identifying protein kinase-specific phosphorylation sites. Nucleic 
Acids Res 33(Web Server issue):W226-229. 
94. Bodenmiller B, Campbell D, Gerrits B, Lam H, Jovanovic M, Picotti P, 
Schlapbach R, & Aebersold R (2008) PhosphoPep: A database of protein 
 133 
phosphorylation sites in model organisms. Nat Biotechnol 26(12):1339-
1340. 
95. Wright PE & Dyson HJ (1999) Intrinsically unstructured proteins: Re-
assessing the protein structure-function paradigm. J Mol Biol 293(2):321-
331. 
96. Gsponer J & Babu MM (2009) The rules of disorder or why disorder rules. 
Prog Biophys Mol Biol 99(2-3):94-103. 
97. Sandhu KS (2009) Intrinsic disorder explains diverse nuclear roles of 
chromatin remodeling proteins. J Mol Recognit 22(1):1-8. 
98. Dijkwel PA & Wenink PW (1986) Structural integrity of the nuclear matrix: 
Differential effects of thiol agents and metal chelators. J Cell Sci 84:53-
67. 
99. Townson SM, Sullivan T, Zhang Q, Clark GM, Osborne CK, Lee AV, & 
Oesterreich S (2000) HET/SAF-B overexpression causes growth arrest 
and multinuclearity and is associated with aneuploidy in human breast 
cancer. Clin Cancer Res 6(9):3788-3796. 
100. Yin W, Xiang P, & Li Q (2005) Investigations of the effect of DNA size in 
transient transfection assay using dual luciferase system. Anal Biochem 
346(2):289-294. 
101. Hammerich-Hille S, Kaipparettu BA, Tsimelzon A, Creighton CJ, Jiang S, 
Polo JM, Melnick A, Meyer R, & Oesterreich S (2010) SAFB1 mediates 
repression of immune regulators and apoptotic genes in breast cancer 
cells. J Biol Chem 285(6):3608-3616. 
102. Li J, Hawkins IC, Harvey CD, Jennings JL, Link AJ, & Patton JG (2003) 
Regulation of alternative splicing by SRrp86 and its interacting proteins. 
Mol Cell Biol 23(21):7437-7447. 
103. Henderson DS (2004) Drosophila cytogenetics protocols (Humana Press 
Totowa, New Jersey ). 
 134 
104. Boehm AK, Saunders A, Werner J, & Lis JT (2003) Transcription factor 
and polymerase recruitment, modification, and movement on dhsp70 in 
vivo in the minutes following heat shock. Mol Cell Biol 23(21):7628-7637. 
105. Richter L, Bone JR, & Kuroda MI (1996) RNA-dependent association of 
the Drosophila maleless protein with the male X chromosome. Genes 
Cells 1(3):325-336. 
106. Angshuman S & Cordula S (2007) An Approach for Immunofluorescence 
of Drosophila S2 Cells. Cold Spring Harbor Protocols. : pdb.prot4760 
107. Linnemann AK & Krawetz SA (2009) Silencing by nuclear matrix 
attachment distinguishes cell-type specificity: Association with increased 
proliferation capacity. Nucleic Acids Res 37(9):2779-2788. 
108. Oesterreich S, Allredl DC, Mohsin SK, Zhang Q, Wong H, Lee AV, 
Osborne CK, & O'Connell P (2001) High rates of loss of heterozygosity 
on chromosome 19p13 in human breast cancer. Br J Cancer 84(4):493-
498. 
109. Debril MB, Dubuquoy L, Feige JN, Wahli W, Desvergne B, Auwerx J, & 
Gelman L (2005) Scaffold attachment factor B1 directly interacts with 
nuclear receptors in living cells and represses transcriptional activity. J 
Mol Endocrinol 35(3):503-517. 
110. Denegri M, Chiodi I, Corioni M, Cobianchi F, Riva S, & Biamonti G (2001) 
Stress-induced nuclear bodies are sites of accumulation of pre-mRNA 
processing factors. Mol Biol Cell 12(11):3502-3514. 
111. Lee YB, Colley S, Norman M, Biamonti G, & Uney JB (2007) SAFB re-
distribution marks steps of the apoptotic process. Exp Cell Res 
313(18):3914-3923. 
112. Dobrzycka KM, Kang K, Jiang S, Meyer R, Rao PH, Lee AV, & 
Oesterreich S (2006) Disruption of scaffold attachment factor B1 leads to 
TBX2 up-regulation, lack of p19ARF induction, lack of senescence, and 
cell immortalization. Cancer Res 66(16):7859-7863. 
 135 
113. Ivanova M, Dobrzycka KM, Jiang S, Michaelis K, Meyer R, Kang K, 
Adkins B, Barski OA, Zubairy S, Divisova J, Lee AV, & Oesterreich S 
(2005) Scaffold attachment factor B1 functions in development, growth, 
and reproduction. Mol Cell Biol 25(8):2995-3006. 
114. Garee JP & Oesterreich S (2010) SAFB1's multiple functions in biological 
control-lots still to be done! J Cell Biochem 109(2):312-319. 
115. Rong YS & Golic KG (2001) A targeted gene knockout in Drosophila. 
Genetics 157(3):1307-1312. 
116. Dobie KW, Kennedy CD, Velasco VM, McGrath TL, Weko J, Patterson 
RW, & Karpen GH (2001) Identification of chromosome inheritance 
modifiers in Drosophila melanogaster. Genetics 157(4):1623-1637. 
117. Nickerson JA, Krockmalnic G, Wan KM, & Penman S (1997) The nuclear 
matrix revealed by eluting chromatin from a cross-linked nucleus. Proc 
Natl Acad Sci USA 94(9):4446-4450. 
118. Hassan AB & Cook PR (1993) Visualization of replication sites in unfixed 
human cells. J Cell Sci 105 ( Pt 2):541-550. 
119. Wan KM, Nickerson JA, Krockmalnic G, & Penman S (1999) The nuclear 
matrix prepared by amine modification. Proc Natl Acad Sci USA 
96(3):933-938. 
120. Poljak L, Seum C, Mattioni T, & Laemmli UK (1994) SARs stimulate but 
do not confer position independent gene expression. Nucleic Acids Res 
22(21):4386-4394. 
121. Tchurikov NA, Krasnov AN, Ponomarenko NA, Golova YB, & Chernov BK 
(1998) Forum domain in Drosophila melanogaster cut locus possesses 
looped domains inside. Nucleic Acids Res 26(13):3221-3227. 
122. Fisher PA, Berrios M, & Blobel G (1982) Isolation and characterization of 
a proteinaceous subnuclear fraction composed of nuclear matrix, 
 136 
peripheral lamina, and nuclear pore complexes from embryos of 
Drosophila melanogaster. J Cell Biol 92(3):674-686. 
123. Mel'nikova LS, Krivega IV, Georgiev PG, & Golovnin AK (2007) Nuclear 
matrix protein EAST is involved in regulation of transcription of the yellow 
gene in Drosophila melanogaster. Dokl Biol Sci 415:313-316. 
124. Schaefer M, Steringer JP, & Lyko F (2008) The Drosophila cytosine-5 
methyltransferase Dnmt2 is associated with the nuclear matrix and can 
access DNA during mitosis. PLoS One 3(1):e1414. 
125. Costa E, Canudas S, Garcia-Bassets I, Perez S, Fernandez I, Giralt E, 
Azorin F, & Espinas ML (2006) Drosophila dSAP18 is a nuclear protein 
that associates with chromosomes and the nuclear matrix, and interacts 
with pinin, a protein factor involved in RNA splicing. Chromosome Res 
14(5):515-526. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 137 
APPENDIX A 
THE IDENTIFICATION AND CHARACTERIZATION OF THE Drosophila 
HOMOLOGUE TO THE HUMAN SCAFFOLD ATTACHMENT FACTOR A 
(SAF-A) 
 
 
INTRODUCTION 
 
 The nuclear matrix contains many different non-histone proteins important 
in DNA replication, transcription and nuclear organization. One of the most 
abundant proteins in the nuclear matrix is the Scaffold Attachment Factor A 
(SAF-A). SAF-A was initially identified as a protein that binds to RNA and is 
present in preparations of hnRNP-complexes, therefore named hnRNP-U (1). 
Richter et al. (2) identified hnRNP-U as a protein that specifically bind to Scaffold 
Attachment Regions (SARs) in HeLa cells, subsequently naming it SAF-A. It has 
been shown biochemically that SAF-A possesses a SAP domain that binds to 
SAR elements, including two SAR elements from the upstream and downstream 
regions of the chicken lysozyme gene domain. (2). Additionally, SAF-A can 
forms large aggregates in vitro and mediates the formation of looped structure 
using these S/MAR DNA sequences (2, 3). 
 SAF-A has been implicated in several functions besides its role in 
chromatin compaction. SAF-A is associated with the transcriptional coactivator 
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p300, a histone acetyltransferase that regulates transcription (4). In addition, 
SAF-A is involved in the replication and mitotic stability of mammalian episomes 
(5) (6). SAF-A represses induced glucocorticoid activation by directly binding the 
glucocorticoid receptor (7), binds rhythmically to Bmal1, an important gene in 
circadian rhythm (9), and is cleaved in its SAP domain at the onset of apoptosis 
(8). 
 SAF-A contains a RNA-binding domain that has shown to be involved in 
binding XIST RNA on the inactive X chromosomes in mammals (9). 
Furthermore, SAF-A enhancing the expression of tumor necrosis factor alpha, 
GADD45A, HEXIM1, HOXA2, IER3, NHLH2, and ZFY, by binding to their mRNA 
and increasing their stability (10).  
 Despite all the knowledge about SAF-A, the importance of this nuclear 
matrix protein and its biological significance in the whole organism is still 
unclear. Therefore, I decided to study Scaffold Attachment Factor A (SAF-A) in a 
simpler model organism, Drosophila melanogaster, by first characterizing the 
protein.  
 Here, I report the discovery and characterization of the Drosophila 
homologue of SAF-A which complements the Drosophila SAFB characterization. 
I describe multiple characteristics of the sequence of the CG30122 gene, which I 
found to be the only Drosophila homologue to human SAF-A. CG30122, 
ubiquitously expressed throughout development in various tissues, is similar to 
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the human saf-a gene. At the cellular lever, Drosophila SAF-A is a nuclear 
protein found throughout the nucleoplasm.  
 
RESULTS AND DISCUSSION    
 
Characterization of the Drosophila CG30122 gene 
 
 SAF-A homologues are found in a variety of vertebrate species such as 
human, mouse, cow and Xenopus (2). Since SAF-A is conserved among 
eukaryotes, I was curious as to whether Drosophila contains a gene that is 
homologous to human saf-a. I analyzed the Drosophila genome using a BLAST 
search program to find predicted homologous sequences. I identified the gene 
CG30122, a 6941 bp sequence whose homology (38% identity) with the human 
SAF-A spans the length of the protein. Computer analysis scanning for motifs in 
CG30122 (comparing with Prosite, PeroxiBase and Pfam libraries), showed that 
the predicted protein contains an N-terminal SAP domain, and a SPRY domain 
(SpIA ryanodine receptor), important for protein-protein interaction (Fig.1A). 
CG30122 also contains an Aspartic acid/Glutamic acid (D/E)-rich domain in its 
N-terminus and a Glycine-rich domain in its C-terminus, like human SAF-A 
(Fig.1A). Human SAF-A possesses an RGG-box that binds to single stranded 
RNA (11). The RGG domain is defined as sequences of closely spaced Arg-Gly-
Gly (RGG) repeats. Proteins that possesses this domain are involved in various 
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aspects of RNA processing, including splicing, stabilizing, transport and 
translation of mRNAs (12). Human SAF-A sequence contains five closely 
spaced RGG repeats at its C-terminus, however, Drosophila 30122 gene has 
just two distant RGG repeats in its C-terminus. Interestingly, Drosophila SAF-A 
also contains five RGY repeats between the RGG sequences (Fig.1A). It would 
be necessary to test if Drosophila SAF-A binds to RNA in vitro and in vivo. 
 
 
 
 
Fig. 1A. A schematic representation of the Drosophila gene CG30122 and its 
human homologue. Drosophila CG30122 possesses the same structural 
features as human SAF-A. Characterized domains (SAP, SPRY) are shown, as 
well as D, E-, G-, and Q- rich regions. The percentages of different amino acids 
are indicated. 
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 Human SAF-A is ubiquitously expressed in multiple tissues, such as liver, 
heart, kidney and lung (2). To determine if CG30122 is ubiquitously expressed in 
the fly, I tested whether it is expressed throughout the Drosophila life cycle, for 
this I performed Reverse transcriptase PCR (RT-PCR). CG30122 mRNA is 
expressed in all life stages, and in soma (heads) and mixed soma/germ (bodies) 
(Fig.2A). These results further support the hypothesis that CG30122 is the 
Drosophila homologue of human SAF-A. 
 
 
 
 
Fig. 2A. CG30122 is ubiquitously expressed. CG30122 mRNA expression was 
analyzed by RT-PCR. 18S rRNA was used as loading control. 
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 To extend these findings, I searched for specific localization of CG30122 
mRNA in different embryonic tissues by RNA in situ hybridization. I used a probe 
I generated against the entire CG30122 sequence to evaluate the expression of 
both mRNAs. The probe showed that CG30122 mRNA is maternally loaded into 
the egg, and is present during all developmental stages of the embryo (Fig.3A A-
H). It is clear that mRNA is present at higher levels in the central nervous system 
after germband extension (Fig.3A E-H).  
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Fig. 3A. CG30122 expression during Drosophila development. A-H. Whole-
mount in situ hybridizations of wild-type embryos were performed with a 
CG30122 RNA probe. A. Syncytial blastoderm embryos show a uniform 
distribution of maternally deposited CG6995 RNA. After maternal RNA 
diminishes, CG30122 mRNA persists in the cellularized blastoderm embryos 
(B), mid-cellularized blastoderm (C), gastrula (D, E), germ-band elongated (F) 
and retracted (G) embryos with higher mRNA expression in the nervous system. 
Late stage embryos show CG6995 mRNA accumulation in the brain and the 
ventral nerve cord (G, H).  
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 In HeLa cells, human SAF-A if found evenly distributed throughout the 
nucleus (13). To determine the nuclear localization of the Drosophila SAF-A, I 
observed the distribution of the protein in S2 cells. Since there are no antibodies 
against Drosophila SAF-A, I made constructs that expressed a SAF-A-GFP 
fusion protein containing an N-terminal or C-terminal GFP-tag under the control 
of Act5C promoter (Fig 4A). 
 
 
 
 
 
Fig.4A. Drosophila SAF-A constructs. Schematic representation of full length 
and SAP-less constructs used in this study. Represented here are the constructs 
containing an N-terminal GFP fusion, but constructs containing a C-terminal 
GFP fusion were also generated. 
 
 
 
 S2 cells were transfected using either the GFP-SAF-A-FL or GFP- Sap-
less-SAF-A constructs and allowed to express for 3 days before analyzing 
intracellular localization by immunofluorescent microscopy. These experiments 
clearly demonstrate that SAF-A is located throughout the nucleus, including the 
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heterochromatin, but excluded from the nucleolus. Additionally, this localization 
is not due to the SAP-domain. 
 
 
 
 
 
Fig. 5A. The Drosophila SAF-A fusion protein is found in the nucleoplasm. 
Confocal image of N-terminal GFP tagged SAF-A protein (GFP-SAF-A) showing 
that the protein is localized to the nucleoplasm, but is excluded from the 
nucleolus. GFP-SAF-A protein lacking DNA binding domain is similarly 
distributed as the full-length protein.  
 
 
 
 Additionally, I determined the distribution of Drosophila SAF-A protein in 
different cell types. To do this, I made a construct containing the SAF-A 
sequence tagged in its N- or C-terminal with GFP, under the control of Upstream 
Activation Sequence (UAS) that was later introduce into flies. Then, I examined 
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the localization of GFP-SAF-A, in large polytene nuclei of Drosophila salivary 
glands. The immunoreactivity of SAF-A showed that the protein is localized to 
the DNA, but not to the nucleolus (Fig.6A). The same results were obtained with 
the SAF-A-GFP construct. 
 
 
 
 
Fig. 6A. Distribution of Drosophila SAF-A in larval salivary gland nuclei. Full 
length GFP-SAF-A binds to the DNA specifically but not to the nucleolus. DNA 
was stained with DAPI. 
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Generation of Drosophila SAF-A knockout by ends-out homologous 
recombination 
 
 Human SAF-A have been associated with a variety of cellular processes, 
however the roles of these scaffold proteins in each of these processes is still 
under investigation. To understand the role that SAF-A plays in nuclear 
organization, I created flies lacking the SAF-A gene by homologous 
recombination (14). The homologous recombination donor construct was 
designed so that the flanking sequences of the Drosophila saf-a gene are 
flanking a white+ gene marker. In this way, after recombination, the Drosophila 
saf-a is replaced with the white+ gene without affecting the genomic sequence of 
adjacent genes (Fig. 7A).  
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Fig. 7A. Diagram representing ends-out targeting. Top shows a transgenic 
donor, which is the basis for targeting and contains I-SceI recognition sites and 
FRTs. FLP and induction in the fly are responsible for the generation of an extra 
chromosomal donor, leaving the remnant at the site of original integration. 
Homology between the extra chromosomal donor and the flanking regions of the 
target causes homologous recombination, replacing the Drosophila saf-a locus 
with white+. 
 
 
 
 Briefly, female flies carrying the targeting construct (P[w+saf-a- ]) were 
crossed to male flies carrying FLP recombinase and I-SceI genes regulated by 
heat-shock promoters. Larvae containing the targeting construct, FLP 
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recombinase and I-SceI were heat shocked at 38° for 1 hr to induce 
recombination. All female progeny (red, white and mosaic eyes) were crossed to 
70FLP/70FLP males to eliminate background in the next generation. Progeny 
with red eyes were then crossed to yw flies to screen for potential homologous 
recombination events. For the ends out homologous recombination strategy, 
1500 crosses were screened. The progeny of these flies were selected based on 
the position of the donor construct on the second chromosome and on the red 
color of the eye.  
 Ten putative homologous recombination events were tested by PCR of 
genomic DNA, using specific primer combinations that align to the white+ gene 
and the outside sequences of the upstream and downstream flanking regions of 
the saf-a gene. There was PCR amplification of the upstream flanking region in 
just one of these events. In contrast, there was no PCR product of the 
downstream region in any of the events tested. Homologous recombination was 
subsequently confirmed by restriction digestion and Southern blotting. Different 
restriction enzymes were used to test the replacement of saf-a by the white+ 
gene. Sequences of the flanking regions were used as probe in southern blots. 
Therefore, whenever saf-a is present in its right location or homologous 
recombination occurs where the white+ gene replaces the saf-a gene, a specific 
pattern of digestion will result using the previously mentioned probes. However, 
if there is excision of the white+ gene and flanking regions from the donor, but no 
recombination with the target, or if there is not excision of the donor at all, the 
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pattern of digestion will be random and unpredicted, depending on the site of 
insertion. Restriction digests were done using the enzymes NheI, EcoRI, PvuI, 
BglII and EcoNI, followed by Southern blot hybridization. This showed that the 
only line positive for PCR in the upstream flanking, is also positive in the 
Southern blot for the upstream flanking, however I did not obtain the expected 
digestion pattern when the Southern was hybridized with the downstream 
flanking probe. This result could be explained if there is an insertion of the white 
gene upstream of saf-a but not a homologous recombination event. The 
experiment was repeated after obtaining new lines with the targeting construct  
(P[w+saf-a- ]). In this case I obtained two possible homologous recombination 
events, however since they were not homozygous lethal I checked for the 
presence of saf-a mRNA. Unfortunately, these two events did not knock out the 
saf-a gene. Further studies will be essential to unravel the biological role of SAF-
A in nuclear matrix and more specifically in gene expression. 
 
MATERALS AND METHODS 
 
Fly stock and genetics  
 
 Flies were maintained on standard cornmeal, yeast, and sugar medium 
with Tegosept. Crosses were performed at 25°. The wild-type was yellow1 
white67c23. The stocks used for ends out gene targeting of SAF-A were: 
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70FLP,70I-SceI: w1118; P{ry+, 70FLP}4, P{v+, 70I-SceI}2B, Sco/S2CyO; + and  
70FLP10: w1118; P{ry+, 70FLP}10/CyO; Sb/TM6,Ubx  
The gal4 drivers used in these studies was: SGS (6870):  w[1118]; 
P{w[+mC]=Sgs3-GAL4.PD}TP1, available from the Bloomington Drosophila 
Stock Center (http://flystocks.bio.indiana.edu) 
 
DNA constructs 
 
Drosophila saf-a was amplified from wild-type genomic DNA using 
Polymerase Chain Reaction and the PCR extended system of 5PRIME with 
Primer: FW 5’CACCATGGATGTGGCGAAGCTG 3’ and RV 
5’CTTCTTGTCGGCACCCGCATTG 3’. The PCR products was cloned into the 
pENTR/D-TOPO Gateway entry vector according to the manufacturer's 
instructions (Invitrogen) and the complete sequence was verified by DNA 
sequencing. saf-a sequence was then excised from pEntr/D-TOPO and ligated 
into, P-element plasmid pTW, pTGW and pTWG, from the Drosophila gateway 
collection, using the LR clonase reaction according to the manufacturer's 
instruction (Invitrogen). These constructs were injected into w1118 embryos by 
standard procedures (Genetic Services Inc.). 
 For ends-in gene targeting, the flanking sequences of the saf-a gene were 
amplified and cloned in the pW25.5 plasmid. To amplify the upstream flanking 
sequence primers FW 5’TTGAGCGAATGGGAATCGAATCA3’ and RV 
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5’TTCATTCTTGCGCTTCAATTTGG 3’ were used. A NotI and Acc65I 
recognition sequences were added respectively at the 5’ of each primer. To 
amplify the downstream flanking sequence, primers 5’ 
TTTGAAGGGTTCCGTTTTCTAG 3’ 5’TTAAAGGGTGTGTAATGCGCTCG3’   
were used. A BsiWI and AscI recognition sequences were added respectively at 
the 5’ of each primer. Both fragments were cloned into pW25.5 plasmid that 
contains a white gene flanked by Acc65I upstream and BsiWI downstream. This 
plasmid was injected into embryos to generate transgenic flies (Genetic Services 
Inc.). These transgenic flies were used to generate a null allele of saf-a by 
homologous recombination (14). 
 
S2 cells transfection 
 
S2 Schneider cells were grown in Schneider medium (GIBCO), 10% Heat 
inactivated fetal bovina serum (GIBCO) and 50 µg/ml penicillin and streptomycin 
(GIBCO). S2 cells were transiently transfected by the calcium phosphate 
precipitation method, with pAWG, pAGW containing either Full length SAF-A 
sequence or the SAP-less sequence incubated for 3 days, and analyzed by 
Immunofluorescence or nuclear matrix extraction.  
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Immunofluorescence and microscopy 
 
For S2 cells, immunofluorecence was carried out as previously described 
(15). Briefly, cells were fixed with 4% paraformaldehyde at 37C for 30 min, while 
the nuclear matrices were fixed with 2% paraformaldehyde at room temperature 
for 15 min. Fixed cells were washed extensively, permeabilized in 0.2 triton x-
100 for 10 min, blocked with bovine serum albumin for 30 min, and incubated 
with primary antibody at 4°C overnight. Primary antibodies used were: antiGFP 
(Santa Cruz) 1:200, anti-Nuclear Pore Complex protein (Covance) 1:200. The 
incubation was followed by secondary antibody. Secondary antibodies used 
were: FITC-conjugated anti-rabbit IgG goat antiserum (Jackson 
Immunoresearch), TRITC-conjugated anti-mouse IgG goat antibodies and 
(Jackson Immunoresearch). All secondaries were used at 1:200 dilution. DAPI 
(1ng/mL) was routinely added to Vectashield (Vector labs) as a mounting 
medium for visualization of DNA.   
 
Southern blots 
  
 DNA from adult flies was prepared using a modified procedure from K. 
Dobie (16). The nucleic acid was cut with the different restriction enzymes 
according to the manufacturer’s specifications (New England Biolabs). DNA was 
separated by electrophoresis on 1% agarose gel and transferred overnight onto 
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nylon membrane by capillary blotting in 1x ABB (1.5M NaCl, 400 mN NaOH).  
Radioactive probes, corresponding to each flanking region of saf-a gene, were 
hybridizing over night in QuickHyb hybridization solution (Stratagene). All blots 
were washed two times at 65°C for 15 min each in C&G1 buffer (40mM Sodium 
phosphate pH7.2, 5% SDS, 1mM EDTA, 0.5% BSA), followed by two times at 
65°C for 15 min each in C&G2 buffer (40mM Sodium phosphate pH7.2, 1% 
SDS, 1mM EDTA). 
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